Abscess of anal and rectal regions

K11_ABSCANAL

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 K61
  • Hospital discharge: ICD-9 566
  • Hospital discharge: ICD-8 566
  • Cause of death: ICD-10 K61
  • Cause of death: ICD-9 566
  • Cause of death: ICD-8 566

2 out of 7 registries used, show all original rules.

3685

4. Check minimum number of events

None

3685

5. Include endpoints

None

3685

6. Filter based on genotype QC (FinnGen only)

3685

Control definitions (FinnGen only)

Control exclude
K11_INTESTOTH

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2
Parent code in ICD-10
K55-K63
Name in latin
Abscessus seu cellulitis regionis analis/rectalis

Case counts by codes

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 30472 8948 21312
Only index persons 26981 8210 18771
Unadjusted period prevalence (%)
Whole population 0.49 0.26 0.60
Only index persons 0.59 0.30 0.72
Median age at first event (years)
Whole population 40.85 42.39 40.14
Only index persons 40.16 41.46 39.59

-FinnGen-

Key figures

All Female Male
Number of individuals 3685 1416 2269
Unadjusted period prevalence (%) 0.80 0.48 1.00
Median age at first event (years) 43.97 41.61 45.45

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
3329
Matched controls
33289
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
5660A
ICD-9 Finland
Abscess of anal and rectal regions[ABSCESSUS ANI ET ANORECTALIS]
+∞
323.0
319
*
P01AB01
ATC
metronidazole; oral, rectal
6.1
323.0
2040
6864
JHA00
NOMESCO Finland
Anal or perianal incision
1539.6
323.0
1520
18
K61.1
ICD-10 Finland
Rectal abscess
+∞
323.0
431
*
JHD20
NOMESCO Finland
Incision of fistula-in-ano
2263.8
323.0
540
*
K60.3
ICD-10 Finland
Anal fistula
3474.9
323.0
1037
*
K61.0
ICD-10 Finland
Anal abscess
4564.2
323.0
2421
19
UJH02
NOMESCO Finland
Anoscopy
28.1
323.0
512
214
L02.3
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of buttock
28.1
323.0
569
242
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
548.4
307.1
301
6
UJF32
NOMESCO Finland
Coloscopy
5.6
297.7
1025
2453
D95
ICPC
Anal fissure/perianal abscess
78.3
276.9
313
44
56600
ICD-8 Finland
Abscess of anal and rectal regions, Abscessus perianalis
+∞
245.9
233
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
10.1
240.2
508
583
K61.2
ICD-10 Finland
Anorectal abscess
829.0
238.6
232
*
K60.1
ICD-10 Finland
Chronic anal fissure
113.9
224.6
243
23
JHD33
NOMESCO Finland
Completing incision of fistula-in-ano
1107.3
214.9
208
*
JHD30
NOMESCO Finland
Incomplete incision of fistula-in-ano
1096.0
212.8
206
*
S10
ICPC
Boil/carbuncle
8.2
211.2
507
714
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
13.6
205.5
371
305
J01DB01
ATC
cefalexin; oral
3.6
166.6
2912
21870
6454
FHL
Incision of perianal abscess
+∞
166.0
158
*
JHW96
NOMESCO Finland
Other operation on anus or perianal tissue
176.8
161.2
168
10
QBA10
NOMESCO Finland
Incision of skin of trunk
25.1
152.0
217
92
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
151.6
1151
5002
UJF30
NOMESCO Finland
Ileoscopy through colon
6.0
143.8
430
804
N02AX02
ATC
tramadol; systemic, rectal
2.6
137.9
1560
8503
J01MA02
ATC
ciprofloxacin; systemic
2.6
136.3
1424
7404
JHA20
NOMESCO Finland
Excision of lesion of anal canal or perianal tissue
58.2
136.2
161
29
K60.4
ICD-10 Finland
Rectal fistula
+∞
133.2
127
*
K50.8
ICD-10 Finland
Other Crohn disease
17.9
132.8
212
126
SPAT1148
SPAT
Treatment of chronic ulcer or burn
3.9
132.4
621
1850
K60.2
ICD-10 Finland
Anal fissure, unspecified
33.9
129.9
171
53
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
6.6
127.6
350
581
6455
FHL
Perianal fistula surgery
636.4
125.2
123
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
408.4
119.4
119
*
A07EC02
ATC
mesalazine; oral, rectal
5.8
114.7
351
668
K50.9
ICD-10 Finland
Crohn disease, unspecified
16.6
108.6
178
113
J01FF01
ATC
clindamycin; systemic
2.5
106.9
1059
5175
TPH04
NOMESCO Finland
Cathetrisation of vein
2.8
103.4
806
3414
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
4.7
100.8
371
864
K61
ICD-10 Finland
Abscess of anal and rectal regions
210.3
99.0
102
5
K50.1
ICD-10 Finland
Crohn disease of large intestine
17.9
98.2
156
91
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
7.5
97.7
243
348
N02BE01
ATC
paracetamol; systemic, rectal
2.6
96.6
2803
22486
JN3BD
NOMESCO Finland
Extensive abdominal CT
4.1
96.5
415
1123
L04AX01
ATC
azathioprine; systemic
5.7
94.3
288
543
K61.3
ICD-10 Finland
Ischiorectal abscess
+∞
93.1
89
*
K60.0
ICD-10 Finland
Acute anal fissure
47.1
93.1
114
25
C05AA08
ATC
fluocortolone; rectal, topical
3.2
93.0
558
1971
JHD50
NOMESCO Finland
Excision of fistula-in-ano with advancement flap of mucosa
+∞
87.9
84
*
5651A
ICD-9 Finland
Anal fissure and fistula, Anal fistula[FISTULA ANI]
+∞
87.9
84
*
WX320
NOMESCO Finland
Spinalanesthesy
2.5
86.1
814
3800
JHD96
NOMESCO Finland
Other incision of anal sphincter
+∞
81.6
78
*
L02.9
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle, unspecified
6.9
80.9
212
326
K50.0
ICD-10 Finland
Crohn disease of small intestine
13.7
79.4
140
106
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.5
78.5
752
3509
A06AC01
ATC
ispaghula (psylla seeds); oral
2.6
78.0
648
2794
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
77.6
838
4156
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.2
77.0
1082
6068
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
6.6
76.9
208
334
A02BC02
ATC
pantoprazole; systemic
2.0
76.4
1989
14275
J01DA01
ATC
[U] cefalexin; systemic
2.0
76.4
2070
15090
J01MA12
ATC
levofloxacin; systemic
2.5
74.0
658
2938
UJG02
NOMESCO Finland
Proctoscopy
12.0
73.0
137
119
S18
ICPC
Laceration/cut
2.0
72.9
1332
8290
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
+∞
70.0
67
*
56510
ICD-8 Finland
Anal fissure and fistula, Anal fistula
+∞
69.0
66
*
A07EA06
ATC
budesonide; oral, local oral
6.4
68.1
187
306
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
68.1
1327
8399
JH1CM
NOMESCO Finland
Perianal extensive MRI with 3 Tesla magnet
660.9
66.2
65
*
S97
ICPC
Chronic ulcer skin
4.6
66.1
245
568
9731
FHL
Opening and channeling of the inflammatory site in the operating room or anesthesia
27.5
65.9
91
34
WX402
NOMESCO Finland
General anaesthesia
2.4
65.9
636
2947
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
8.1
65.9
153
196
ZX120
NOMESCO Finland
Intravenous
3.2
64.3
365
1219
S85
ICPC
Pilonidal cyst/fistula
73.7
63.3
72
10
L02
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle
5.1
62.3
206
423
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
4.9
58.4
200
426
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
4.6
57.9
213
489
H02AB06
ATC
prednisolone; systemic
1.8
57.2
1411
9533
A07EA02
ATC
hydrocortisone; rectal
7.0
57.0
146
217
L05.0
ICD-10 Finland
Pilonidal cyst with abscess
11.6
56.5
107
95
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
16.4
55.9
91
57
K51.5
ICD-10 Finland
Left sided colitis
5.6
55.8
171
321
L05.9
ICD-10 Finland
Pilonidal cyst without abscess
8.4
55.5
126
156
K60.5
ICD-10 Finland
Anorectal fistula
546.7
54.7
54
*
WX002
NOMESCO Finland
Sedation and analgesia
2.2
51.5
603
3030
A06AD11
ATC
lactulose; oral
2.7
49.6
381
1539
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
43.6
48.6
60
14
SPAT1149
SPAT
Suture or treatment of traumatic wound
2.4
47.4
437
1950
JG1CG
NOMESCO Finland
Extensive MRI of rectum
22.0
47.1
69
32
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
3.4
46.1
237
731
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
18.8
45.4
70
38
Z93.3
ICD-10 Finland
Colostomy status
20.4
45.3
68
34
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
45.3
534
2677
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.7
44.5
335
1335
I84.9
ICD-10 Finland
Unspecified hemorrhoids without complication
4.3
44.0
171
414
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.7
43.5
204
584
N02AJ06
ATC
codeine and paracetamol; systemic
1.7
43.2
1179
8013
XJH00
NOMESCO Finland
Transanal ultrasonography
3.3
42.9
234
754
XJW99
NOMESCO Finland
Other investigative procedure on digestive system
39.2
42.9
54
14
K61.4
ICD-10 Finland
Intrasphincteric abscess
+∞
42.8
41
*
UJF14
NOMESCO Finland
Enteroscopy of ileoanal anastomosis
23.0
42.3
61
27
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
4.3
41.4
159
381
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.7
41.3
1427
10342
K62.0
ICD-10 Finland
Anal polyp
60.8
41.3
48
8
K56.7
ICD-10 Finland
Ileus, unspecified
60.8
41.3
48
8
JHD10
NOMESCO Finland
Myotomy of anal sphincter
145.1
40.8
43
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.1
40.5
235
788
UJF92
NOMESCO Finland
Capsular endoscopy
8.2
40.4
92
115
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.5
40.3
341
1449
45599
ICD-8 Finland
Haemorrhoids
+∞
39.7
38
*
JFF23
NOMESCO Finland
Transversostomy
13.2
39.6
70
54
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
4.9
39.4
134
284
L73.2
ICD-10 Finland
Hidradenitis suppurativa
9.3
38.9
82
90
WX110
NOMESCO Finland
Local anesthesy
1.6
38.9
2193
18001
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.6
38.8
1591
12004
D04
ICPC
Rectal/anal pain
8.5
38.8
86
103
H02AB07
ATC
prednisone; oral
2.2
38.4
424
2054
N02AA05
ATC
oxycodone; systemic
2.3
37.7
401
1908
4AA12
NOMESCO Finland
NA
22.8
37.5
54
24
K59.09
ICD-10 Finland
Constipation, unspecified
5.4
36.9
115
221
6453
FHL
Radical surgery of hemorrhoids
192.1
36.8
38
*
L02.8
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of other sites
7.0
36.7
93
137
SPAT1262
SPAT
Handing over of treatment supplies
2.0
36.2
549
3031
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.8
36.2
744
4576
B01AB05
ATC
enoxaparin; parenteral
1.8
36.1
799
5034
R50.9
ICD-10 Finland
Fever, unspecified
2.1
35.9
450
2300
Z93.2
ICD-10 Finland
Ileostomy status
38.0
35.6
45
12
K51.8
ICD-10 Finland
Other ulcerative colitis
7.3
35.5
87
122
XF400
NOMESCO Finland
ECG with 12 standard connections
2.0
35.5
479
2525
K62.8
ICD-10 Finland
Other specified diseases of anus and rectum
26.4
34.1
47
18
R4110
NOMESCO Finland
Physiotherapy
1.7
34.0
781
4961
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
5.8
33.6
98
174
QXA05
NOMESCO Finland
Skin division, unspecified location
19.2
33.5
51
27
K62.6
ICD-10 Finland
Ulcer of anus and rectum
15.5
33.4
55
36
56500
ICD-8 Finland
Anal fissure and fistula, Anal fissure
+∞
33.4
32
*
JHD00
NOMESCO Finland
Anal dilatation
33.5
33.1
43
13
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
9.6
32.5
67
71
103
Kela drug reimbursment
Diabetes, insulin-treated
1.7
32.5
772
4945
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
20.3
32.2
48
24
JAH00
NOMESCO Finland
Laparotomy
5.5
32.2
98
184
L04AB04
ATC
adalimumab; parenteral
4.9
31.7
106
221
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
5.5
31.7
96
179
6459
FHL
Other measure in this category
30.4
31.6
42
14
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
4.4
31.5
117
272
56601
ICD-8 Finland
Abscess of anal and rectal regions, Abscessus periproctalis
+∞
31.3
30
*
K59.1
ICD-10 Finland
Functional diarrhoea
4.6
31.2
111
247
C03CA01
ATC
furosemide; systemic
1.8
31.0
621
3765
J01AA02
ATC
doxycycline; systemic
1.6
31.0
2307
19638
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
8.4
30.9
69
84
C05AA01
ATC
hydrocortisone; rectal, topical
3.2
30.9
170
551
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
11.3
30.3
57
51
5650B
ICD-9 Finland
Anal fissure and fistula, Anal fissure[FISSURA ANI TYPICA]
+∞
30.2
29
*
JHD64
NOMESCO Finland
Intersphincteric closure of anal fistula (ligation of intersphincteric fistula tract, LIFT)
+∞
30.2
29
*
R15
ICD-10 Finland
Faecal incontinence
7.2
30.1
74
105
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.1
30.0
387
1995
JHB00
NOMESCO Finland
Hemorrhoidectomy
4.5
30.0
110
253
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
29.5
524
3048
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.4
29.4
274
1217
JFF10
NOMESCO Finland
Loop enterostomy
16.4
29.3
47
29
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
2.7
29.2
210
811
WX702
NOMESCO Finland
Supraglottic ventilation device
2.8
29.0
195
720
1470
FHL
Rectoscopy
28.2
28.9
39
14
J02AC01
ATC
fluconazole; systemic
1.6
28.9
982
6908
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
28.8
1052
7531
C10AC01
ATC
colestyramine; oral
5.3
28.7
89
171
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
4.2
28.7
112
274
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
28.5
474
2690
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
6.4
28.5
76
121
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
2.1
28.2
344
1731
N03AX16
ATC
pregabalin; oral
1.7
28.1
636
3991
215
Kela drug reimbursment
Diabetes, non-insulin-treated
1.7
27.9
703
4553
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.6
27.8
808
5444
6451
FHL
Dilatation
100.9
27.7
30
*
K51.0
ICD-10 Finland
Ulcerative (chronic) pancolitis
8.8
27.4
59
68
N05CF01
ATC
zopiclone; oral
1.6
27.4
820
5566
M01AE01
ATC
ibuprofen; systemic, rectal
1.7
27.4
2884
26265
JFB00
NOMESCO Finland
Partial resection of small intestine
9.5
27.1
56
60
K56.0
ICD-10 Finland
Paralytic ileus
273.1
26.7
27
*
K52.88
ICD-10 Finland
Other specified noninfective gastroenteritis and colitis
5.6
26.5
78
141
K50
ICD-10 Finland
Crohn disease [regional enteritis]
19.3
26.5
40
21
E66.01
ICD-10 Finland
Obesity due to excess calories
2.3
26.0
247
1107
SPAT1146
SPAT
Puncture of abscess or incision of skin
4.5
26.0
94
214
N75.1
ICD-10 Finland
Abscess of Bartholin gland
10.3
26.0
51
50
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
4.3
25.9
99
238
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.3
25.8
256
1170
K62.1
ICD-10 Finland
Rectal polyp
40.4
25.8
32
8
K60
ICD-10 Finland
Fissure and fistula of anal and rectal regions
40.4
25.8
32
8
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
40.4
25.8
32
8
K62.9
ICD-10 Finland
Disease of anus and rectum, unspecified
27.2
25.7
35
13
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
2.4
25.5
228
993
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
25.4
309
1549
R03AC02
ATC
salbutamol; inhalant
1.5
25.4
1476
11647
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
1.9
25.2
408
2287
QX3HE
NOMESCO Finland
Ultrsound examination of lesion close to skin
6.4
25.2
67
107
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
+∞
25.0
24
*
TJF80
NOMESCO Finland
Ostomy education
9.6
24.9
51
54
L02.4
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of limb
3.3
24.9
132
417
K65.0
ICD-10 Finland
Acute peritonitis
8.6
24.8
54
64
UKC02
NOMESCO Finland
Cystoscopy
1.9
24.7
408
2303
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
19.7
24.7
37
19
JGA96
NOMESCO Finland
Other proctotomy or local operation on rectum
90.8
24.7
27
*
I84.5
ICD-10 Finland
External hemorrhoids without complication
4.1
24.5
98
246
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
3.8
24.2
104
278
E66.8
ICD-10 Finland
Other obesity
2.6
24.1
179
704
SPAT1263
SPAT
Sampling
1.5
23.8
1165
8824
A10AE04
ATC
insulin glargine; parenteral
2.1
23.8
300
1526
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.0
23.8
308
1583
A02BC05
ATC
esomeprazole; systemic
1.5
23.7
1035
7645
Z71.8
ICD-10 Finland
Other specified counselling
1.6
23.6
663
4399
WX892
NOMESCO Finland
Monitored bed care
2.3
23.6
223
995
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
23.3
580
3721
K59.0
ICD-10 Finland
Constipation
3.8
23.3
99
263
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
3.2
23.0
123
392
A10AB05
ATC
insulin aspart; parenteral (insulins and analog. for injection, fast-acting)
2.2
22.9
253
1214
D94
ICPC
Chronic enteritis/ulcerative colitis
11.2
22.9
43
39
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.7
22.8
579
3734
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
8.4
22.8
50
60
K51.2
ICD-10 Finland
Ulcerative (chronic) proctitis
5.3
22.8
70
134
M79.6
ICD-10 Finland
Pain in limb
1.5
22.8
911
6588
E0000UV
ATC
NA
1.5
22.6
1070
8028
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
2.2
22.6
246
1175
A10BA02
ATC
metformin; oral
1.6
22.4
718
4922
N05BA04
ATC
oxazepam; oral
1.6
22.2
631
4196
K92.1
ICD-10 Finland
Melaena
3.1
22.1
123
403
A02BC01
ATC
omeprazole; systemic
1.6
22.1
669
4515
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
5.1
22.1
70
139
L01BB02
ATC
mercaptopurine; oral
7.5
22.1
52
70
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.5
21.9
832
5933
WX400
NOMESCO Finland
Inhalation anesthesy
2.8
21.9
147
546
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.7
21.8
467
2864
TPH07
NOMESCO Finland
Cathetrisation of artery
2.0
21.8
276
1407
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
38.9
21.7
27
7
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
21.7
1656
13633
JG1BG
NOMESCO Finland
MRI of rectum
12.8
21.6
38
30
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
21.5
343
1908
A07DA03
ATC
loperamide; oral
3.4
21.5
108
329
C07AB07
ATC
bisoprolol; oral
1.5
21.5
1139
8727
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
3.3
21.2
108
332
QDB10
NOMESCO Finland
Major dressing of wound of skin of lower limb
2.7
21.1
149
569
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.5
21.0
169
694
N06AX11
ATC
mirtazapine; oral
1.5
21.0
821
5887
SPAT1301
SPAT
No procedures
1.5
20.5
808
5795
E11
ICD-10 Finland
Type 2 diabetes mellitus
1.8
20.4
407
2441
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.1
20.3
237
1165
4AB02
NOMESCO Finland
NA
10.1
20.3
40
40
I70.2
ICD-10 Finland
Atherosclerosis of arteries of extremities
2.2
20.2
206
955
M01AE02
ATC
naproxen; oral, rectal
1.4
20.2
1608
13267
N05BA01
ATC
diazepam; systemic, rectal
1.8
20.1
350
2006
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
3.6
20.1
93
266
L28
ICPC
Limited function/disability (L)
1.9
20.1
335
1894
N03AX12
ATC
gabapentin; oral
1.8
19.9
391
2329
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.3
19.8
195
889
WZC30
NOMESCO Finland
Teaching
1.8
19.6
368
2159
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
16.5
19.6
31
19
XF600
NOMESCO Finland
Bloodpressure measurement
2.3
19.6
183
813
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.1
19.4
242
1225
M03BX02
ATC
tizanidine; oral
1.4
19.3
1819
15410
J45.9
ICD-10 Finland
Asthma, unspecified
1.7
19.3
436
2711
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
15.6
19.2
31
20
R60.0
ICD-10 Finland
Localized oedema
2.0
19.0
254
1322
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
2.3
19.0
177
785
K59.4
ICD-10 Finland
Anal spasm
55.3
18.9
22
*
R03BB04
ATC
tiotropium bromide; inhalant
2.0
18.9
240
1224
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
6.4
18.8
49
77
JHD60
NOMESCO Finland
Occlusion of fistula-in-ano with use of collagen
+∞
18.8
18
*
N06AB04
ATC
citalopram; systemic
1.6
18.7
548
3651
JFF26
NOMESCO Finland
Sigmoidostomy
70.3
18.7
21
*
K63.2
ICD-10 Finland
Fistula of intestine
191.0
18.5
19
*
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
2.0
18.5
235
1197
M54.5
ICD-10 Finland
Low back pain
1.5
18.5
877
6524
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.5
18.5
904
6766
D01
ICPC
Abdominal pain/cramps general
2.0
18.4
243
1259
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.4
18.4
1245
9915
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
5.9
18.4
51
87
QWC00
NOMESCO Finland
Reoperation for superficial infection in surgery of skin
9.1
18.3
38
42
QDA10
NOMESCO Finland
Incision of skin of lower limb
7.2
18.3
44
62
JHA10
NOMESCO Finland
Biopsy of anal canal
44.2
18.2
22
5
R06.0
ICD-10 Finland
Dyspnoea
1.6
18.2
554
3724
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.8
18.2
345
2029
A07EC01
ATC
sulfasalazine; oral, rectal
2.0
18.2
237
1223
A02BA02
ATC
ranitidine; systemic
1.7
18.1
437
2767
XPX99
NOMESCO Finland
Other diagnostic examination of periferal vessel
2.4
18.0
162
708
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
6.6
17.9
46
71
L01BC06
ATC
capecitabine; oral
3.1
17.9
102
339
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.0
17.8
103
348
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.4
17.8
87
261
Z01.8
ICD-10 Finland
Other specified special examinations
1.6
17.6
545
3680
K62.3
ICD-10 Finland
Rectal prolapse
36.9
17.6
22
6
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
17.6
373
2272
JN2BD
NOMESCO Finland
Extensive CT exmaniation of lower part of abdomen
15.7
17.5
28
18
ZXA00
NOMESCO Finland
Right side
1.5
17.2
664
4717
J01MA14
ATC
moxifloxacin; systemic
2.0
17.1
237
1251
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
14.8
17.1
28
19
M03BC01
ATC
orphenadrine (citrate); systemic
1.5
17.0
656
4659
T90
ICPC
Diabetes non-insulin dependent
1.5
16.9
567
3897
JFB46
NOMESCO Finland
Resection of sigmoid colon
10.1
16.9
33
33
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
16.8
2110
18552
K51.3
ICD-10 Finland
Ulcerative (chronic) rectosigmoiditis
4.0
16.8
67
170
JN4BD
NOMESCO Finland
Extensive body CT
1.9
16.8
267
1482
K62.4
ICD-10 Finland
Stenosis of anus and rectum
+∞
16.7
16
*
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.4
16.7
148
643
J01FA10
ATC
azithromycin; systemic
1.4
16.6
1665
14091
N05AH04
ATC
quetiapine; oral
1.6
16.6
457
2990
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
16.6
571
3949
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
16.5
1398
11509
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.1
16.4
188
918
B01AB10
ATC
tinzaparin; parenteral
2.2
16.4
174
822
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
16.3
220
1149
G04CA02
ATC
tamsulosin; oral
1.5
16.2
582
4066
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
9.2
16.1
33
36
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
16.1
455
2998
N06AA09
ATC
amitriptyline; systemic
2.0
16.1
223
1178
D11
ICPC
Diarrhoea
1.8
16.1
294
1711
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.5
16.0
718
5256
A07AA09
ATC
vancomycin; oral
6.2
15.9
42
68
M25.5
ICD-10 Finland
Pain in joint
1.5
15.9
721
5290
N06AX16
ATC
venlafaxine; oral
1.7
15.8
364
2272
JX1LA
NOMESCO Finland
Kinetic X-ray of alimentary tract with pictures
33.5
15.7
20
6
JFH30
NOMESCO Finland
Total colectomy, mucosal proctectomy and ileoanal anastomosis without ileostomy
15.7
15.7
25
16
L72.1
ICD-10 Finland
Trichilemmal cyst
2.1
15.6
181
889
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.7
15.6
353
2187
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
5.9
15.5
43
74
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
15.5
444
2935
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
3.8
15.5
66
178
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
15.5
1365
11269
J01CF05
ATC
flucloxacillin; systemic
2.5
15.5
122
499
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.4
15.4
1137
9109
E11.7
ICD-10 Finland
Type 2 diabetes mellitus, with multiple complications
2.4
15.4
131
556
SPAT1125
SPAT
Stoma care and guidance
6.0
15.4
42
71
XJG12
NOMESCO Finland
Transrectal endoscopic ultrasonography
38.2
15.4
19
5
A02BC03
ATC
lansoprazole; oral
1.5
15.3
668
4856
AA1AD
NOMESCO Finland
CT of head and brain
1.5
15.3
543
3774
N06AX21
ATC
duloxetine; oral
1.8
15.1
267
1535
K59.00
ICD-10 Finland
Constipation caused by slow bowel passage (SCT)
10.8
15.0
28
26
L17
ICPC
Foot/toe symptom/complaint
1.5
14.8
585
4158
R02
ICPC
Shortness of breath/dyspnoea
1.8
14.8
265
1531
JFH10
NOMESCO Finland
Total colectomy and ileostomy
31.8
14.8
19
6
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
31.8
14.8
19
6
R06AE07
ATC
cetirizine; oral
1.4
14.7
1155
9335
S04
ICPC
Lump/swelling localized
1.8
14.7
241
1352
4550A
ICD-9 Finland
Haemorrhoids, Internal haemorrhoids without mention of complication
+∞
14.6
14
*
5651B
ICD-9 Finland
Anal fissure and fistula, Anal fistula[FISTULA ANORECTALIS]
+∞
14.6
14
*
JAJ00
NOMESCO Finland
Rectal incision and drainage of pelvic abscess
+∞
14.6
14
*
JFG73
NOMESCO Finland
Excision of ileal pelvic pouch
80.4
14.6
16
*
JHB96
NOMESCO Finland
Other procedure for haemorrhoids or prolapse of mucosa
11.9
14.5
26
22
A10BB12
ATC
glimepiride; oral
2.1
14.5
164
798
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
14.2
14.5
24
17
M01AH05
ATC
etoricoxib; oral
1.3
14.5
1655
14172
D64.9
ICD-10 Finland
Anaemia, unspecified
2.0
14.5
198
1040
C20
ICD-10 Finland
Malignant neoplasm of rectum
8.9
14.4
30
34
A03FA01
ATC
metoclopramide; systemic, rectal
1.5
14.3
469
3197
M04AA01
ATC
allopurinol; systemic
1.7
14.3
300
1817
A46
ICD-10 Finland
Erysipelas
1.7
14.3
345
2177
5552A
ICD-9 Finland
Regional enteritis, Small intestine with large intestine
27.3
14.3
19
7
N05BA12
ATC
alprazolam; oral
1.8
14.2
251
1442
D06AX01
ATC
fusidic acid; topical (antibiotics for topical use)
1.8
14.2
265
1550
UJF34
NOMESCO Finland
Left colonoscopy
9.1
14.2
29
32
L02.0
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of face
3.7
14.1
61
167
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.5
14.1
479
3292
SPAT1156
SPAT
Guidance concerning treatment of rash and skin
1.7
14.1
306
1874
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.3
14.0
42
80
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.9
14.0
222
1232
ZXA05
NOMESCO Finland
Left side
1.5
14.0
612
4444
Z93
ICD-10 Finland
Artificial opening status
15.8
13.9
22
14
K59.01
ICD-10 Finland
Constipation outlet obstruction type
30.1
13.9
18
6
L97
ICD-10 Finland
Ulcer of lower limb, not elsewhere classified
2.7
13.9
95
360
R03AK07
ATC
formoterol and budesonide; inhalant
1.5
13.9
500
3485
L01BA01
ATC
methotrexate; systemic (folic acid analog.)
2.6
13.7
104
415
R53
ICD-10 Finland
Malaise and fatigue
1.5
13.7
449
3060
R10.0
ICD-10 Finland
Acute abdomen
3.0
13.7
79
268
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.5
13.6
64
188
R33
ICD-10 Finland
Retention of urine
2.0
13.6
175
899
H02AB04
ATC
methylprednisolone; systemic
1.6
13.6
341
2175
FM1AE
NOMESCO Finland
Standard cardiac ultrasound examination
1.6
13.6
413
2768
4556A
ICD-9 Finland
Haemorrhoids, Unspecified haemorrhoids without mention of complication
+∞
13.5
13
*
4553A
ICD-9 Finland
Haemorrhoids, External haemorrhoids without mention of complication
+∞
13.5
13
*
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
10.9
13.5
25
23
K63.0
ICD-10 Finland
Abscess of intestine
140.5
13.5
14
*
JHC40
NOMESCO Finland
Encircling suture of anus
140.5
13.5
14
*
JGA98
NOMESCO Finland
Other transluminal endoscopic local operation on rectum
140.5
13.5
14
*
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.8
13.4
247
1441
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
7.7
13.3
30
39
G47.3
ICD-10 Finland
Sleep apnoea
1.5
13.3
589
4280
I84.1
ICD-10 Finland
Internal hemorrhoids with other complications
3.5
13.3
62
181
K02.1
ICD-10 Finland
Caries of dentine
1.3
13.3
1702
14739
J01FA06
ATC
roxithromycin; oral
1.4
13.3
1044
8402
3AC01
NOMESCO Finland
NA
5.2
13.3
40
77
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
9.1
13.2
27
30
N01BB02
ATC
lidocaine; parenteral
6.1
13.1
35
58
SPAT1254
SPAT
Administration of medicine
1.6
13.1
319
2019
A06AC51
ATC
ispaghula, combinations; systemic
2.5
13.0
100
403
R4190
NOMESCO Finland
Nutritional therapy
2.5
13.0
103
424
J01DA06
ATC
[U] cefuroxime; systemic
1.6
12.9
378
2504
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
12.8
610
4493
WX290
NOMESCO Finland
Other blockade of nerve
1.3
12.8
1325
11106
L04AC05
ATC
ustekinumab; parenteral
8.5
12.7
27
32
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
10.5
12.7
24
23
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.8
12.7
236
1380
TK800
NOMESCO Finland
Hemodialysis
3.0
12.7
73
248
TKC20
NOMESCO Finland
Catheterisation of bladder
2.0
12.6
167
866
N06AB10
ATC
escitalopram; oral
1.5
12.6
507
3612
A28
ICPC
Limited function/disability NOS
1.7
12.6
259
1561
LFA00
NOMESCO Finland
Incision of vulva or perineum
32.1
12.6
16
5
S29
ICPC
Skin symptom/complaint other
1.5
12.5
406
2758
A10BH01
ATC
sitagliptin; oral
1.8
12.5
217
1241
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
4.3
12.5
45
105
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
8.2
12.5
27
33
K56.2
ICD-10 Finland
Volvulus
+∞
12.5
12
*
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
1.6
12.5
298
1873
N75.8
ICD-10 Finland
Other diseases of Bartholin gland
9.3
12.5
25
27
I84.4
ICD-10 Finland
External hemorrhoids with other complications
4.6
12.4
42
92
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.8
12.4
217
1243
WF001
NOMESCO Finland
Preoperative radiotherapy
5.4
12.4
36
67
R01AD09
ATC
mometasone; nasal
1.3
12.3
1197
9927
K51
ICD-10 Finland
Ulcerative colitis
5.0
12.3
38
76
JF1BD
NOMESCO Finland
Very extensive small bowel CT
10.5
12.2
23
22
K62.2
ICD-10 Finland
Anal prolapse
37.7
12.2
15
*
D18
ICPC
Change in faeces/bowel movements
3.8
12.2
51
137
J01CA04
ATC
amoxicillin; systemic
1.3
12.1
2401
21978
L89
ICD-10 Finland
Decubitus ulcer and pressure area
4.3
12.1
44
104
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
11.1
12.0
22
20
R31
ICD-10 Finland
Unspecified haematuria
1.8
12.0
226
1327
JFF27
NOMESCO Finland
Laparoscopic sigmoidostomy
21.3
12.0
17
8
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.4
11.9
687
5237
SPAT1211
SPAT
Application of soft bandage
1.8
11.9
209
1201
JFF13
NOMESCO Finland
Terminal enterostomy
46.8
11.9
14
*
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
46.8
11.9
14
*
130
Kela drug reimbursment
Malignant tumour
1.8
11.9
200
1134
SPAT1255
SPAT
Intravenous administration of medicine
2.0
11.8
157
818
QXB99
NOMESCO Finland
Other procedure to treat skin wound, unspecified location
3.6
11.8
52
146
TQX10
NOMESCO Finland
Biopsy of skin and subcutaneous tissue
1.8
11.8
221
1296
M07.4*K50.9
ICD-10 Finland
Arthropathy in Crohn's disease [regional enteritis]
11.7
11.8
21
18
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
11.7
11.8
21
18
285
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.1
11.7
134
655
B01AA03
ATC
warfarin; systemic
1.5
11.7
395
2708
K64.9
ICD-10 Finland
Haemorrhoids, unspecified
3.6
11.6
52
148
5561A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) ileocolitis
12.6
11.6
20
16
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.1
11.6
135
666
1490
FHL
Sigmoideoscopy (fiberscope)
23.0
11.6
16
7
N06AB03
ATC
fluoxetine; oral
1.6
11.5
289
1843
N76.4
ICD-10 Finland
Abscess of vulva
8.6
11.5
24
28
JGA00
NOMESCO Finland
Proctotomy
+∞
11.5
11
*
K63.3
ICD-10 Finland
Ulcer of intestine
+∞
11.5
11
*
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
2.6
11.4
84
333
XCK10
NOMESCO Finland
Photography of fundus of eye
1.7
11.4
231
1386
N07BA03
ATC
varenicline; oral
1.9
11.4
168
911
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.4
11.4
566
4196
M02AA07
ATC
piroxicam; topical
1.3
11.3
840
6667
TQW99
NOMESCO Finland
Other minor procedure on skin
2.2
11.3
117
551
J01FA09
ATC
clarithromycin; systemic
1.3
11.3
822
6508
J44.0
ICD-10 Finland
Chronic obstructive pulmonary disease with acute lower respiratory infection
2.4
11.2
96
413
B03BA03
ATC
hydroxocobalamin; parenteral
2.1
11.2
119
566
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.6
11.2
310
2025
R10.2
ICD-10 Finland
Pelvic and perineal pain
3.1
11.2
61
202
5551A
ICD-9 Finland
Regional enteritis, Large intestine
25.1
11.1
15
6
N82.3
ICD-10 Finland
Fistula of vagina to large intestine
25.1
11.1
15
6
R01BA52
ATC
pseudoephedrine, combinations; oral
1.4
11.1
754
5899
369
Kela drug reimbursment
Regorafenib
20.1
11.1
16
8
J01MA06
ATC
norfloxacin; oral
1.6
11.0
273
1733
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.7
11.0
237
1448
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
3.1
11.0
58
188
L84
ICD-10 Finland
Corns and callosities
2.4
11.0
88
367
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.6
11.0
321
2128
SPAT1151
SPAT
Treatment of major wounds
3.8
10.9
45
120
I84
ICD-10 Finland
Hemorrhoids
2.8
10.9
68
244
G44.2
ICD-10 Finland
Tension-type headache
1.6
10.9
285
1838
D16
ICPC
Rectal bleeding
3.4
10.8
51
152
QBB99
NOMESCO Finland
Other procedure for wound of skin of trunk
15.5
10.8
17
11
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
3.7
10.7
45
122
E66.00
ICD-10 Finland
Metabolic syndrome
1.9
10.7
146
768
L01BC59
ATC
trifluridine, combinations; systemic
17.9
10.7
16
9
D07AC01
ATC
betamethasone; topical
1.3
10.7
859
6893
Z00.0
ICD-10 Finland
General medical examination
1.5
10.7
446
3194
QBE05
NOMESCO Finland
Excision of sweat glands or sweat gland bearing skin from trunk
21.5
10.7
15
7
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
21.5
10.7
15
7
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
3.7
10.6
45
123
JFG50
NOMESCO Finland
Laparotomy with revision of enterostomy or colostomy
60.2
10.6
12
*
5991A
ICD-9 Finland
Other disorders of urethra and urinary tract, Urethral fistula
60.2
10.6
12
*
A03FA02
ATC
cisapride; oral, rectal
1.9
10.6
143
750
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
10.6
570
4288
D07AD01
ATC
clobetasol; topical
1.5
10.5
361
2479
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.5
10.5
81
330
N05CF02
ATC
zolpidem; oral
1.5
10.5
422
3000
M48.0
ICD-10 Finland
Spinal stenosis
1.7
10.5
232
1428
WVA20
NOMESCO Finland
Medicine administration
2.9
10.5
63
223
N05CD07
ATC
temazepam; oral
1.6
10.5
245
1532
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
3.1
10.5
57
189
A41.9
ICD-10 Finland
Sepsis, unspecified
2.4
10.5
84
350
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.6
10.4
293
1922
H01
ICPC
Ear pain/earache
1.6
10.4
254
1604
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.7
10.4
205
1221
JHC60
NOMESCO Finland
Transanal submucous or intersphincteric injection
+∞
10.4
10
*
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
2.8
10.4
65
234
R03AC03
ATC
terbutaline; inhalant
1.5
10.3
327
2208
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
2.4
10.3
83
347
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.6
10.3
254
1613
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.3
10.3
713
5592
JFB33
NOMESCO Finland
Other resection comprising small intestine and colon
18.8
10.2
15
8
WW500
NOMESCO Finland
Blood transfusion
2.3
10.2
95
427
JGB36
NOMESCO Finland
Wide excision of rectum
23.4
10.2
14
6
A07AA02
ATC
nystatin; oral
2.0
10.2
123
619
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
10.2
1117
9359
JN2AD
NOMESCO Finland
CT examination of lower part of abdomen
13.1
10.1
17
13
K76.0
ICD-10 Finland
Fatty (change of) liver, not elsewhere classified
2.8
10.1
64
233
R74
ICPC
Upper respiratory infection acute
1.3
10.1
735
5798
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.2
10.1
101
467
XX9XW
NOMESCO Finland
NA
4.7
10.1
33
71
M01AB05
ATC
diclofenac; systemic, rectal
1.3
10.0
1878
16817
SPAT1260
SPAT
Consultation of another employee
1.5
10.0
405
2879
D06
ICPC
Abdominal pain localized other
1.8
10.0
162
908
X59
ICD-10 Finland
Exposure to unspecified factor
1.4
10.0
477
3503
Z01.6
ICD-10 Finland
Radiological examination, not elsewhere classified
1.6
10.0
235
1472
JFH20
NOMESCO Finland
Proctocolectomy and ileostomy
40.2
10.0
12
*
WZC10
NOMESCO Finland
Extensive specialist consultion with written report
2.0
9.9
125
638
M01AX17
ATC
nimesulide; oral
1.4
9.9
531
3984
D12.9
ICD-10 Finland
Benign neoplasm: Anus and anal canal
7.6
9.9
22
29
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
9.9
349
2412
346
Kela drug reimbursment
Dulaglutide, exenatide, liraglutide, lixisenatide and semaglutide (adults)
2.0
9.9
118
591
QDB05
NOMESCO Finland
Revision of wound of skin of lower limb
2.6
9.8
68
263
M03BC51
ATC
orphenadrine, combinations; systemic
1.3
9.8
706
5558
R22.9
ICD-10 Finland
Localized swelling, mass and lump, unspecified
1.8
9.8
171
982
RD210
NOMESCO Finland
NA
2.8
9.8
59
210
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.7
9.7
190
1131
J01MA01
ATC
ofloxacin; systemic
1.7
9.7
193
1152
C03DA01
ATC
spironolactone; oral
1.7
9.7
218
1350
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
9.7
1502
13121
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
9.7
742
5902
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
2.8
9.5
60
218
K63.5
ICD-10 Finland
Polyp of colon
10.0
9.5
18
18
WX725
NOMESCO Finland
Noninvasive ventilation
2.0
9.5
116
588
WX610
NOMESCO Finland
Patient controlled analgesia
5.4
9.5
27
50
UJD02
NOMESCO Finland
Gastroscopy
2.1
9.5
99
469
R11
ICD-10 Finland
Nausea and vomiting
1.8
9.4
155
872
NB1AA
NOMESCO Finland
Shoulder X-ray examination without contrast
1.9
9.4
136
733
K96
ICPC
Haemorrhoids
2.7
9.4
61
227
L03
ICPC
Low back symptom/complaint
1.4
9.4
541
4108
K55.2
ICD-10 Finland
Angiodysplasia of colon
100.3
9.4
10
*
JG1DG
NOMESCO Finland
Very extensive MRI of rectum
30.1
9.4
12
*
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
2.1
9.4
108
533
5690A
ICD-9 Finland
Other disorders of intestine, Anal and rectal polyp
+∞
9.4
9
*
5621B
ICD-9 Finland
Diverticula of intestine, Colon[DIVERTICULITIS COLI SINE HAEMORRHAGIA]
+∞
9.4
9
*
JFA38
NOMESCO Finland
Endoscopic dilatation of small intestine
+∞
9.4
9
*
M54.4
ICD-10 Finland
Lumbago with sciatica
1.5
9.4
379
2696
L01XE21
ATC
[U] regorafenib; oral
21.7
9.3
13
6
T81.9
ICD-10 Finland
Unspecified complication of procedure
3.1
9.3
48
154
J01AA07
ATC
tetracycline; systemic
1.4
9.3
403
2903
TQW40
NOMESCO Finland
Remowal of suture of skin
1.7
9.3
179
1061
J01FA01
ATC
erythromycin; systemic
1.5
9.3
360
2539
5568X
ICD-9 Finland
Idiopathic proctocolitis, Other ulcerative colitis
10.7
9.3
17
16
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.7
9.3
189
1140
N07BB01
ATC
disulfiram; oral
1.9
9.3
142
781
R52.2
ICD-10 Finland
Other chronic pain
2.4
9.3
77
329
JAD10
NOMESCO Finland
Repair of incisional hernia
6.4
9.2
23
36
D07CC01
ATC
betamethasone and antibiotics; topical
1.5
9.2
313
2147
F10.1
ICD-10 Finland
Mental and behavioural disorders due to use of alcohol, Harmful use
1.7
9.2
195
1187
L03.1
ICD-10 Finland
Cellulitis of other parts of limb
2.4
9.2
73
303
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.5
9.2
291
1965
J01EA01
ATC
trimethoprim; systemic
1.4
9.2
450
3320
I50.9
ICD-10 Finland
Heart failure, unspecified
1.6
9.1
219
1381
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.0
9.1
121
631
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.5
9.1
290
1959
WX722
NOMESCO Finland
PEEP
2.0
9.1
115
592
A10BK03
ATC
empagliflozin; oral
1.7
9.1
180
1074
XXA00
NOMESCO Finland
Clinical examination requiring general anaesthesia
5.3
9.0
26
49
1XC07
NOMESCO Finland
NA
15.6
9.0
14
9
JFG30
NOMESCO Finland
Closure of colostomy with resection of exteriorised loop
36.8
9.0
11
*
JF1CM
NOMESCO Finland
Small bowel extensive MRI with with high intensity magnet
36.8
9.0
11
*
R5140
NOMESCO Finland
Monitoring the use of the aid
1.5
9.0
271
1811
M01AH01
ATC
celecoxib; oral (coxibs)
1.4
9.0
382
2746
D07AB02
ATC
hydrocortisone butyrate; topical
1.3
9.0
662
5227
N06AX12
ATC
bupropion; oral
1.8
9.0
165
963
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
3.2
9.0
44
137
L40.0
ICD-10 Finland
Psoriasis vulgaris
1.9
8.9
122
645
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.4
8.9
72
303
5560A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) enterocolitis
18.6
8.9
13
7
JHC10
NOMESCO Finland
Reconstruction of anal sphincter without graft
24.1
8.9
12
5
E000001
ATC
NA
1.4
8.9
501
3790
56300
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Regional enteritis
12.5
8.9
15
12
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
1.7
8.8
166
978
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
6.8
8.8
21
31
M54
ICD-10 Finland
Dorsalgia
1.5
8.8
263
1754
KFA40
NOMESCO Finland
Incision of scrotum
8.6
8.8
18
21
JGA05
NOMESCO Finland
Endoscopic polypectomy in rectum
8.6
8.8
18
21
JN4CD
NOMESCO Finland
Very extensive body CT
2.2
8.7
89
417
SPAT1153
SPAT
Removal of sutures
1.3
8.7
737
5933
UJF02
NOMESCO Finland
Peroral enteroscopy
5.9
8.7
23
39
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
1.9
8.7
132
724
NE1AA
NOMESCO Finland
Pelvis X-ray examination
1.9
8.7
128
696
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.5
8.7
67
276
8471
FHL
Incision (and possible drainage)
50.1
8.7
10
*
S01
ICPC
Pain/tenderness of skin
2.1
8.7
96
468
A01AB09
ATC
miconazole; local oral
1.7
8.7
166
982
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
6.6
8.6
21
32
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
4.1
8.6
32
79
A03
ICPC
Fever
1.4
8.6
416
3061
E11.4
ICD-10 Finland
Type 2 diabetes mellitus, with neurological complications
2.6
8.6
59
227
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.8
8.6
153
884
N08.39*E11.2
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic nephropathy
3.7
8.6
36
99
A07EA01
ATC
prednisolone; rectal
6.1
8.6
22
36
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
2.2
8.6
86
402
176
Kela drug reimbursment
Regorafenib
11.6
8.6
15
13
R51.80
ICD-10 Finland
Headache
1.5
8.6
330
2323
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.3
8.5
829
6800
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.6
8.5
203
1280
U05
ICPC
Urination problems other
2.1
8.5
90
431
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
1.6
8.5
223
1442
1370
FHL
Colonoscopy, whole colon
6.4
8.5
21
33
6419
FHL
Other measure in this category
20.1
8.5
12
6
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.5
8.4
278
1895
L04AA01
ATC
[U] ciclosporin; systemic
3.1
8.4
43
138
M79.1
ICD-10 Finland
Myalgia
1.5
8.4
276
1877
KH1AD
NOMESCO Finland
CT of urinary organs
2.1
8.4
87
412
K57.0
ICD-10 Finland
Diverticular disease of small intestine with perforation and abscess
90.3
8.4
9
*
JAH01
NOMESCO Finland
Laparoscopy
2.1
8.4
89
425
K04.08
ICD-10 Finland
Other specified pulpit
1.7
8.4
182
1117
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
2.8
8.4
50
178
Z76.0
ICD-10 Finland
Issue of repeat prescription
1.4
8.4
347
2482
S76
ICPC
Skin infection other
1.9
8.3
121
655
R01AD08
ATC
fluticasone; nasal
1.3
8.3
697
5597
5650C
ICD-9 Finland
Anal fissure and fistula, Anal fissure[FISSURA ANI ALIA]
+∞
8.3
8
*
6452
FHL
Sphincterotomy
+∞
8.3
8
*
K604, K603
ICD-10 Finland
NA
+∞
8.3
8
*
205
Kela drug reimbursment
Chronic hypertension
1.3
8.3
569
4436
SPAT1229
SPAT
Assessment of need for aid
1.8
8.3
136
766
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
2.9
8.3
49
173
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
2.0
8.3
104
531
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
1.9
8.3
113
599
EBA05
NOMESCO Finland
Complicated extraction of tooth
1.4
8.3
516
3964
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.6
8.2
231
1515
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
1.8
8.2
130
726
A10AE05
ATC
insulin detemir; parenteral
1.7
8.2
150
877
R05FB02
ATC
cough suppressants and expectorants
1.3
8.2
872
7234
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
14.5
8.2
13
9
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
14.5
8.2
13
9
L04AA06
ATC
mycophenolic acid; systemic
2.7
8.2
52
191
Z51.5
ICD-10 Finland
Palliative care
1.9
8.2
118
639
196
Kela drug reimbursment
Paricalcitol and cinacalcet
6.5
8.2
20
31
A04AA01
ATC
ondansetron; systemic, rectal
1.8
8.2
142
816
E66
ICD-10 Finland
Obesity
2.0
8.2
105
542
XF402
NOMESCO Finland
ECG with work load test
1.6
8.2
233
1534
J01CE02
ATC
phenoxymethylpenicillin; oral
1.2
8.1
2054
18805
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
3.5
8.1
36
104
M05BA04
ATC
alendronic acid; oral
1.9
8.1
119
644
R03BA02
ATC
budesonide; inhalant
1.4
8.1
392
2882
PBL10
NOMESCO Finland
Construction of arteriovenous fistula from radial artery
3.7
8.1
33
89
R05FA02
ATC
opium derivatives and expectorants; systemic
1.3
8.1
982
8277
C09AA02
ATC
enalapril; systemic
1.4
8.1
416
3096
EBA00
NOMESCO Finland
Extraction of tooth
1.3
8.0
878
7306
A10BB01
ATC
glibenclamide; oral
2.2
8.0
79
366
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
3.1
8.0
42
138
I15.1
ICD-10 Finland
Hypertension secondary to other renal disorders
3.4
8.0
37
111
A04
ICPC
Weakness/tiredness general
1.5
7.9
248
1672
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.1
7.9
83
396
L08.8
ICD-10 Finland
Other specified local infections of skin and subcutaneous tissue
2.3
7.9
70
309
SPAT1216
SPAT
Assessment of functional ability
1.5
7.9
274
1891
PG1DE
NOMESCO Finland
Other extensive ultrasound examination of artery
2.0
7.9
97
496
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
5.7
7.8
21
37
N30.0
ICD-10 Finland
Acute cystitis
1.6
7.8
219
1440
L04AD01
ATC
ciclosporin; systemic
2.6
7.8
54
210
L05
ICD-10 Finland
Pilonidal cyst
10.8
7.8
14
13
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
1.8
7.8
130
741
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.3
7.8
624
4978
E86
ICD-10 Finland
Volume depletion
2.8
7.8
48
176
JN4AD
NOMESCO Finland
Body CT examination
1.7
7.7
161
979
R06AX27
ATC
desloratadine; oral
1.3
7.7
663
5337
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
3.8
7.7
31
83
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.6
7.7
54
212
5550A
ICD-9 Finland
Regional enteritis, Small intestine
15.0
7.7
12
8
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
1.9
7.7
110
596
R03AC12
ATC
salmeterol; inhalant
2.0
7.7
91
459
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.6
7.7
214
1405
JL5AG
NOMESCO Finland
Simple MRI examinaiton of bile and pancreas ducts with high intesity magnet
4.4
7.6
26
60
JGB50
NOMESCO Finland
Mucosal proctectomy and ileoanal anastomosis
18.4
7.6
11
6
N49.9
ICD-10 Finland
Inflammatory disorder of unspecified male genital organ
8.0
7.6
16
20
R35
ICD-10 Finland
Polyuria
1.8
7.6
124
700
O99.6
ICD-10 Finland
Diseases of the digestive system complicating pregnancy, childbirth and the puerperium
4.9
7.6
23
47
K64.3
ICD-10 Finland
Fourth degree haemorrhoids
11.9
7.6
13
11
JFH33
NOMESCO Finland
Total colectomy, mucosal proctectomy, ileoanal anastomosis and ileostomy
25.1
7.6
10
*
SGA01
NOMESCO Finland
Tooth opening as first aid
1.4
7.6
436
3308
SPAT1312
SPAT
General health counselling
1.3
7.6
773
6368
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
7.6
410
3075
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.4
7.5
471
3618
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.3
7.5
66
292
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.2
7.5
1633
14649
QXB10
NOMESCO Finland
Exchange of dressing for large skin wound, unspecified location
8.9
7.5
15
17
190
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
3.7
7.5
31
85
N05AA02
ATC
levomepromazine; systemic
1.9
7.5
106
568
J01DC02
ATC
cefuroxime; systemic
1.7
7.5
143
846
L01
ICPC
Neck symptom/complaint
1.5
7.5
285
2004
K85.9
ICD-10 Finland
Acute pancreatitis, unspecified
2.7
7.5
49
186
J01.0
ICD-10 Finland
Acute maxillary sinusitis
1.3
7.5
486
3757
N06AB05
ATC
paroxetine; oral
1.7
7.5
150
905
K86.1
ICD-10 Finland
Other chronic pancreatitis
4.0
7.4
28
71
L04AX03
ATC
methotrexate; systemic (immunosuppressants)
1.5
7.4
216
1430
C07AA05
ATC
propranolol; systemic
1.4
7.4
430
3264
P76
ICPC
Depressive disorder
1.7
7.4
139
822
Z03.5
ICD-10 Finland
Observation for other suspected cardiovascular diseases
1.7
7.4
161
993
N03AX09
ATC
lamotrigine; oral
1.8
7.4
115
640
D05AX52
ATC
calcipotriol, combinations; topical
1.7
7.4
140
827
E87.6
ICD-10 Finland
Hypokalaemia
2.4
7.4
59
250
D07XC01
ATC
betamethasone, combinations; topical
1.5
7.3
283
1995
TQW80
NOMESCO Finland
Local dermatologic skincare
2.3
7.3
62
270
D07BA04
ATC
hydrocortisone and antiseptics; topical
1.5
7.3
243
1658
P03
ICPC
Feeling depressed
1.5
7.3
209
1380
E11.2
ICD-10 Finland
Type 2 diabetes mellitus, with renal complications
2.2
7.3
69
314
R52.9
ICD-10 Finland
Pain, unspecified
1.6
7.3
168
1049
5651C
ICD-9 Finland
Anal fissure and fistula, Anal fistula[FISTULA RECTALIS]
+∞
7.3
7
*
LEE20
NOMESCO Finland
Closure of urovaginal fistula using graft or flap
+∞
7.3
7
*
6408
FHL
Colectomy and ileostomy
+∞
7.3
7
*
M86.9
ICD-10 Finland
Osteomyelitis, unspecified
4.2
7.3
26
63
NHQ40
NOMESCO Finland
Amputation of toe
2.9
7.2
42
147
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
2.3
7.2
63
277
I50.0
ICD-10 Finland
Congestive heart failure
1.8
7.2
114
639
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
2.8
7.2
44
161
127
Kela drug reimbursment
Transplant complication
2.6
7.2
48
185
M14.6*A52.1
ICD-10 Finland
Charcot's or tabetic arthropathy
7.3
7.2
16
22
L08.9
ICD-10 Finland
Local infection of skin and subcutaneous tissue, unspecified
2.3
7.2
63
279
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.0
7.2
87
443
K63.9
ICD-10 Finland
Disease of intestine, unspecified
20.0
7.1
10
5
N06AX26
ATC
vortioxetine; oral
1.7
7.1
131
769
R13
ICD-10 Finland
Dysphagia
1.8
7.1
127
737
A10AA02
ATC
NA
1.9
7.1
97
516
WX882
NOMESCO Finland
High dependency care
2.2
7.1
68
314
R63.4
ICD-10 Finland
Abnormal weight loss
2.3
7.1
60
262
ZX100
NOMESCO Finland
Oral
3.3
7.0
33
101
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.7
7.0
135
802
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
1.5
7.0
201
1330
123
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
2.3
7.0
57
245
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.2
7.0
1127
9781
K08.3
ICD-10 Finland
Retained dental root
1.6
7.0
171
1089
J45.1
ICD-10 Finland
Nonallergic asthma
1.7
6.9
145
885
N32.1
ICD-10 Finland
Vesicointestinal fistula
13.8
6.9
11
8
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
1.5
6.9
198
1311
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.7
6.9
132
783
SPAT1310
SPAT
Counselling related to known health issue
1.3
6.9
748
6201
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1.9
6.9
97
523
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
4.8
6.8
21
44
WW200
NOMESCO Finland
Immunization
2.0
6.8
78
389
K86.00
ICD-10 Finland
Acute pancreatitis caused by alcohol
2.7
6.8
44
165
QBG99
NOMESCO Finland
Other operation for chronic ulcer or fistula of skin
10.9
6.8
12
11
QBG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of trunk
10.9
6.8
12
11
H04.10
ICD-10 Finland
Dry eye syndrome
1.6
6.8
188
1235
6851A
ICD-9 Finland
Pilonidal cyst, Without mention of abscess
4.2
6.8
24
58
C03EA01
ATC
hydrochlorothiazide and potassium-sparing agents; oral
1.5
6.8
249
1737
L02
ICPC
Back symptom/complaint
1.6
6.8
189
1242
JG1CM
NOMESCO Finland
Extensive MRI of rectum (more than 1.5 T)
40.1
6.8
8
*
JHB20
NOMESCO Finland
Sclerotherapy of haemorrhoids
40.1
6.8
8
*
XKD00
NOMESCO Finland
Uroflowmetry
1.4
6.8
345
2561
G63.2*E11.4
ICD-10 Finland
Non-insulin-dependent diabetes mellitus - Diabetic polyneuropathy
3.7
6.7
27
73
R42
ICD-10 Finland
Dizziness and giddiness
1.3
6.7
413
3161
R05
ICPC
Cough
1.3
6.7
496
3903
JAF10
NOMESCO Finland
Repair of umbilical hernia
2.3
6.7
60
269
UJK12
NOMESCO Finland
Peroral cholangioscopy
7.2
6.7
15
21
JF1AD
NOMESCO Finland
Small bowel CT
7.2
6.7
15
21
SFA40
NOMESCO Finland
Replacement of krone of tooth
1.3
6.7
509
4023
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.3
6.7
599
4844
E10.1
ICD-10 Finland
Type 1 diabetes mellitus, With ketoacidosis
2.6
6.7
45
175
L03.3
ICD-10 Finland
Cellulitis of trunk
4.1
6.7
24
59
A02BA04
ATC
nizatidine; systemic
1.6
6.7
147
909
R03BA01
ATC
beclometasone; inhalant
1.4
6.7
304
2213
D06BB04
ATC
podophyllotoxin; topical
1.7
6.7
142
871
D07BC01
ATC
betamethasone and antiseptics; topical
1.4
6.7
270
1924
L03.9
ICD-10 Finland
Cellulitis, unspecified
2.4
6.7
51
212
D10
ICPC
Vomiting
1.7
6.6
145
893
Z72.0
ICD-10 Finland
Tobacco use
2.1
6.6
72
351
D07AB08
ATC
desonide; topical
1.5
6.6
236
1636
J44
ICD-10 Finland
Other chronic obstructive pulmonary disease
2.6
6.6
45
176
TKC22
NOMESCO Finland
Catheterisation instruction
2.5
6.6
47
187
F31.8
ICD-10 Finland
Other bipolar affective disorders
2.4
6.6
51
213
F33.10
ICD-10 Finland
Recurrent depression, moderate episode without somatic syndrome
1.7
6.6
121
710
JGB10
NOMESCO Finland
Partial proctectomy and end colostomy
12.3
6.6
11
9
L98.4
ICD-10 Finland
Chronic ulcer of skin, not elsewhere classified
2.7
6.6
41
153
E10.00
ICD-10 Finland
Insulin-dependent diabetes diabetic hypoglycemic coma
2.7
6.6
40
147
XG466
NOMESCO Finland
Sleep oxymetry
2.0
6.5
78
395
M01AH02
ATC
rofecoxib; oral
1.5
6.5
249
1752
A01
ICPC
Pain general/multiple sites
1.6
6.5
144
893
WX704
NOMESCO Finland
Intubation
1.6
6.5
163
1043
T36
ICD-10 Finland
Poisoning by systemic antibiotics
1.8
6.5
109
621
XF404
NOMESCO Finland
Ambulatory ECG
1.5
6.5
195
1304
R03DA04
ATC
theophylline; systemic, rectal
1.8
6.5
96
527
JEA00
NOMESCO Finland
Appendectomy
1.6
6.5
153
964
J01FA15
ATC
telithromycin; oral
1.5
6.5
231
1603
N06AA12
ATC
doxepin; systemic
1.8
6.5
105
592
Z49.2
ICD-10 Finland
Other dialysis
3.8
6.5
25
66
V03AE02
ATC
sevelamer; oral
4.5
6.5
21
47
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.7
6.4
138
847
A10AD01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.4
6.4
52
221
OAB50
SPAT
NA
2.9
6.4
37
129
K04.1
ICD-10 Finland
Necrosis of pulp
1.4
6.4
264
1887
WX306
NOMESCO Finland
Lumbar epidural anesthesy
1.7
6.4
126
756
TNX05
NOMESCO Finland
Simple incision of soft tissue, unspecified region
7.4
6.4
14
19
K04.0
ICD-10 Finland
Pulpitis
1.4
6.4
261
1862
O80.0
ICD-10 Finland
Spontaneous vertex delivery
0.7
6.4
240
3276
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.6
6.4
154
977
B81
ICPC
Anaemia vit B12/folate deficiency
2.1
6.4
66
317
A02BA03
ATC
famotidine; systemic
2.1
6.4
66
317
T82
ICPC
Obesity
1.9
6.4
87
463
KMAK
NOMESCO Finland
NA
1.2
6.4
1451
13002
R52.0
ICD-10 Finland
Acute pain
2.1
6.4
70
344
F41.9
ICD-10 Finland
Anxiety disorder, unspecified
1.5
6.4
198
1336
E11.3
ICD-10 Finland
Type 2 diabetes mellitus, with ophthalmic complications
2.1
6.3
65
311
R22.2
ICD-10 Finland
Localized swelling, mass and lump, trunk
2.0
6.3
70
347
R19.5
ICD-10 Finland
Other faecal abnormalities
3.5
6.3
27
78
H92.0
ICD-10 Finland
Otalgia
1.8
6.3
102
579
LFF96
NOMESCO Finland
Other operation on Bartholin gland
18.0
6.3
9
5
JFA76
NOMESCO Finland
Closure of fistula of small intestine
+∞
6.2
6
*
5645A
ICD-9 Finland
Functional digestive disorders, not elsewhere classified, Functional diarrhoea
+∞
6.2
6
*
4AC05
NOMESCO Finland
NA
+∞
6.2
6
*
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.7
6.2
126
760
ZX112
NOMESCO Finland
Subcutaneous
2.4
6.2
48
200
D07AC13
ATC
mometasone; topical
1.3
6.2
691
5737
R32
ICD-10 Finland
Unspecified urinary incontinence
2.5
6.2
46
189
A48.0
ICD-10 Finland
Gas gangrene
26.7
6.2
8
*
PD1BD
NOMESCO Finland
Extensive CT of abdominal aorta and branches
4.3
6.2
21
49
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
1.7
6.2
131
802
A10AD05
ATC
insulin aspart; parenteral (insulins and analog. for injection, intermediate- or long-acting comb. with fast-acting)
2.8
6.2
37
134
H60
ICD-10 Finland
Otitis externa
1.7
6.2
107
620
J45
ICD-10 Finland
Asthma
1.5
6.2
193
1303
JFB43
NOMESCO Finland
Left hemicolectomy
6.3
6.2
15
24
JF2BD
NOMESCO Finland
Extensive colon CT
6.3
6.2
15
24
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.6
6.2
150
956
N20.0
ICD-10 Finland
Calculus of kidney
2.3
6.1
51
222
212
Kela drug reimbursment
Gout
2.5
6.1
45
184
M47.2
ICD-10 Finland
Other spondylosis with radiculopathy
1.6
6.1
132
814
L16
ICPC
Ankle symptom/complaint
1.5
6.1
204
1396
Z03
ICD-10 Finland
Medical observation and evaluation for suspected diseases and conditions, ruled out
1.6
6.1
159
1027
QBE99
NOMESCO Finland
Other excision or repair of lesion of skin of trunk
2.4
6.1
50
214
ZZR00
NOMESCO Finland
Flap of skin
2.4
6.1
50
214
N03AE01
ATC
clonazepam; systemic
1.7
6.1
118
703
JG1JB
NOMESCO Finland
Defekography with X-ray
7.7
6.1
13
17
F33.2
ICD-10 Finland
Recurrent depressive disorder, current episode severe without psychotic symptoms
1.7
6.1
111
650
N08.39*E10.2
ICD-10 Finland
Insulin-dependent diabetes mellitus - Diabetic nephropathy
3.4
6.1
27
80
WX872
NOMESCO Finland
Intensive care
1.7
6.1
115
684
QD9S1
NOMESCO Finland
Photography of skin or subcutaneous tissue in lower extremities, unspecified
4.2
6.1
21
50
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.5
6.1
205
1407
Z49.1
ICD-10 Finland
Extracorporeal dialysis
2.9
6.1
35
122
K04.00
ICD-10 Finland
Hyperemia of pulp
1.7
6.1
114
674
PG5RT
NOMESCO Finland
PTA of arterio-venous shunt for dialysis
8.6
6.0
12
14
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.4
6.0
286
2096
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.3
6.0
454
3580
Z09.8
ICD-10 Finland
Follow-up examination after other treatment for other conditions
2.0
6.0
68
339
D07AA02
ATC
hydrocortisone; topical
1.4
6.0
315
2352
NE1CM
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with 3 Tesla magnet
6.7
6.0
14
21
I84.6
ICD-10 Finland
Residual hemorrhoidal skin tags
6.7
6.0
14
21
G95.8
ICD-10 Finland
Other specified diseases of spinal cord
10.0
6.0
11
11
WX110
SPAT
NA
1.7
6.0
117
699
N03AG01
ATC
valproic acid; systemic, rectal
1.6
6.0
145
919

LabWAS

OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3042936) Bacteria identified in Isolate by Culture
1227
3570
4.65
307.65
2.4
2.0
—
—
—
0
0
(3022145) Colonoscopy Study observation
704
2198
3.72
190.10
1.7
1.3
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
1407
6658
2.80
185.95
5.4
4.3
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
764
2771
3.22
160.71
4.5
2.4
ug/g
177.4
135.6
2.03
661
2229
(3044640) Blood type and Crossmatch panel - Blood
1499
8020
2.47
146.12
3.4
2.2
—
—
—
0
0
(3024561) Albumin [Mass/volume] in Serum or Plasma
1751
10758
2.20
115.74
8.6
4.8
g/l
35.3
36.2
8.99
1673
10010
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1155
6112
2.30
108.90
3.4
2.2
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
440
1438
3.34
107.42
2.0
1.6
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1909
12442
2.11
104.79
5.1
3.8
—
—
—
0
0
(3007853) Bacteria identified in Skin by Aerobe culture
704
3100
2.57
98.94
1.9
1.7
—
—
—
0
0
(3033658) Prothrombin time (PT) actual/Normal
1228
6893
2.17
98.26
5.5
3.8
%
90.7
91.1
0.24
1197
6729
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1954
13323
1.99
89.41
7.9
6.1
umol/l
11.4
11.9
0.79
1861
12668
(3013826) Glucose [Moles/volume] in Serum or Plasma
2208
15788
1.99
87.16
6.0
4.5
mmol/l
7.0
6.7
3.97
2109
14720
(3013650) Neutrophils [#/volume] in Blood by Automated count
2211
15915
1.97
84.41
13.1
8.9
e9/l
4.4
4.1
8.63
1948
13911
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
102
113
9.26
83.91
4.1
3.2
mg/l
8.8
8.4
0.17
86
92
(3013115) Eosinophils [#/volume] in Blood
2029
14351
1.92
79.70
9.4
6.1
e9/l
0.2
0.2
0.37
1811
12696
(3001604) Monocytes [#/volume] in Blood
1971
13826
1.91
79.21
9.0
5.8
e9/l
0.6
0.6
2.01
1735
12026
(42870588) Differential panel, method unspecified - Blood
1445
9158
1.95
78.89
8.6
5.9
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
1974
13873
1.91
78.67
9.1
5.8
e9/l
0.0
0.0
0.19
1736
12068
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1030
5802
2.08
78.53
2.9
2.0
mg/l
3.0
2.8
1.60
905
4979
(3022096) Basophils/100 leukocytes in Blood
1821
12524
1.90
76.97
9.3
6.0
%
0.7
0.7
1.25
1724
11775
(3019198) Lymphocytes [#/volume] in Blood
2005
14319
1.88
74.37
8.9
5.8
e9/l
1.9
2.0
1.79
1798
12688
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
92
106
8.88
73.40
2.9
2.7
au/ml
236.6
121.6
—
6
19
(3019069) Monocytes/100 leukocytes in Blood
1857
12991
1.87
73.05
9.4
6.2
%
8.7
8.6
0.62
1764
12271
(3006504) Eosinophils/100 leukocytes in Blood
1848
12909
1.87
73.03
9.3
6.0
%
2.8
2.9
0.15
1757
12126
(3032080) INR in Blood by Coagulation assay
1549
10239
1.88
72.83
8.7
8.3
inr
1.2
1.2
0.97
438
3055
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
2663
20987
1.97
71.41
11.4
6.9
u/l
80.0
77.4
2.23
2555
19849
(3002030) Lymphocytes/100 leukocytes in Blood
1890
13447
1.83
68.93
9.3
6.0
%
27.1
28.5
7.10
1791
12662
(3018010) Neutrophils/100 leukocytes in Blood
1866
13255
1.83
68.12
9.1
5.8
%
58.4
56.7
7.97
1776
12523
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1231
7712
1.90
67.05
3.4
2.4
u/l
55.7
57.6
0.67
1149
7158
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
3368
29415
2.69
64.17
22.1
11.4
mg/l
28.1
23.1
13.83
2996
22610
(3014576) Chloride [Moles/volume] in Serum or Plasma
608
3127
2.13
56.94
10.2
7.3
mmol/l
104.7
104.6
0.42
597
3058
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1716
12433
1.71
53.85
9.2
6.6
mmol/l
1.2
1.2
3.08
1486
10530
(3031040) Bacteria [#/volume] in Urine by Automated count
2163
16791
1.70
51.56
4.7
3.6
e6/l
1482.1
886.9
0.19
27
235
(3002582) Erythrocytes [#/volume] in Urine
1170
7702
1.76
51.23
3.8
3.0
e6/l
77.8
103.1
0.35
933
5863
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1576
11287
1.69
50.63
8.1
5.9
mmol/l
1.2
1.2
1.42
1463
10299
(3013707) Erythrocyte sedimentation rate by Westergren method
2505
20285
1.73
50.58
4.8
3.6
mm/h
13.4
10.5
14.89
2352
18910
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1407
9779
1.71
50.52
2.1
1.8
pmol/l
92.6
95.7
1.61
816
5297
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
477
2345
2.19
49.69
3.2
2.5
u/l
34.1
60.1
0.70
424
2050
(3030467) Casts [#/volume] in Urine by Automated count
1075
6973
1.76
49.16
3.8
2.9
e6/l
0.5
0.4
0.69
824
5201
(3018095) Leukocytes [#/volume] in Urine
1320
9069
1.71
49.11
4.3
3.4
e6/l
109.7
76.2
0.52
976
6315
(36304419) Bacteria [Presence] in Urine
1064
6887
1.77
48.98
3.6
2.9
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
469
2313
2.18
48.40
3.0
2.2
g/l
0.2
0.2
0.27
439
2155
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
237
864
2.86
46.91
1.8
1.6
iu/ml
0.0
5.6
0.82
49
166
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
1461
10424
1.67
46.44
2.9
2.2
nmol/l
73.4
74.7
1.04
1342
9540
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1564
11379
1.65
45.89
3.5
2.6
ug/l
143.5
136.9
0.38
1472
10641
(3004789) Transferrin [Mass/volume] in Serum or Plasma
618
3449
1.95
45.34
3.1
2.4
g/l
2.4
2.3
0.65
588
3212
(3012095) Magnesium [Moles/volume] in Serum or Plasma
713
4178
1.88
45.09
4.6
3.7
mmol/l
0.8
0.8
4.27
672
3934
(3019550) Sodium [Moles/volume] in Serum or Plasma
3335
29868
2.23
44.95
22.6
13.0
mmol/l
139.4
139.7
17.07
3290
29076
(40758558) Short blood count panel - Blood
1037
6820
1.72
44.32
10.3
6.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
433
2144
2.16
44.03
10.2
8.9
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
654
3765
1.90
43.55
3.1
2.4
umol/l
12.3
14.1
8.18
627
3511
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
580
3216
1.95
43.21
3.2
2.5
%
21.2
24.7
6.71
523
2775
(3000850) Epithelial cells [#/volume] in Urine
830
5191
1.77
42.03
3.1
2.5
e6/l
5.9
5.0
1.02
757
4551
(3023103) Potassium [Moles/volume] in Serum or Plasma
3334
30008
2.17
41.85
23.0
13.1
mmol/l
4.0
4.0
0.84
3285
29153
(40768804) Tissue Pathology biopsy report
1441
10455
1.62
41.54
2.3
2.0
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
529
2891
1.97
40.96
3.6
3.0
umol/l
8.0
8.6
0.22
465
2528
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1321
9407
1.63
40.93
3.8
3.2
u/l
33.3
34.9
0.51
1264
8950
(3026782) Osmolality of Urine
778
4812
1.78
40.78
3.4
2.6
mosm/kgh2o
544.0
565.5
1.88
683
4112
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
206
755
2.83
40.31
2.1
1.7
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
2266
18417
1.60
39.72
4.9
3.6
—
—
—
0
0
(3003458) Phosphate [Moles/volume] in Serum or Plasma
580
3301
1.90
39.70
8.9
6.4
mmol/l
1.1
1.0
0.50
547
3093
(3026008) Bacteria identified in Urine by Culture
946
6271
1.68
38.32
3.2
2.6
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
62
96
6.55
38.31
2.9
1.9
mg/l
9.5
8.8
0.43
55
81
(3014111) Lactate [Moles/volume] in Serum or Plasma
424
2198
2.05
37.94
8.4
7.6
mmol/l
1.3
1.4
1.72
412
2107
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
417
2155
2.05
37.62
5.4
4.1
ug/l
29.4
27.8
0.04
333
1741
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
162
548
3.05
36.61
1.3
1.2
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
1643
12612
1.55
35.35
13.2
8.7
e9/l
0.0
0.0
0.27
1363
10318
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
644
3930
1.77
34.76
2.0
1.8
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
420
2266
1.96
33.39
5.2
4.2
mmol/l
1.5
1.9
1.08
351
1831
(3021447) Carbon dioxide [Partial pressure] in Venous blood
421
2290
1.95
32.64
5.2
4.1
kpa
5.8
5.9
0.25
408
2224
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
642
3982
1.74
32.55
3.2
2.8
e6/l
3.6
2.0
2.28
345
2143
(3052851) Hemolysis interference index of Serum or Plasma
182
703
2.67
32.17
3.4
2.9
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
455
2565
1.88
31.62
9.0
8.2
%
95.9
95.9
0.07
442
2473
(3017143) Hepatitis C virus Ab [Presence] in Serum
600
3679
1.75
31.59
1.8
1.6
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
531
3142
1.81
31.58
1.3
1.2
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
268
1248
2.24
31.45
5.3
4.6
mmol/l
23.8
24.2
1.07
248
1122
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
668
4232
1.71
31.25
3.1
2.6
e6/l
1.1
1.0
0.42
372
2380
(3003396) Base excess in Arterial blood by calculation
495
2879
1.83
31.12
8.8
7.7
mmol/l
0.5
1.0
1.41
388
2238
(3019309) Folate [Moles/volume] in Red Blood Cells
645
4058
1.71
30.92
1.8
1.7
nmol/l
1141.4
1146.5
0.05
505
3116
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
494
2888
1.82
30.51
8.8
7.7
kpa
5.2
5.1
0.31
468
2760
(3027801) Oxygen [Partial pressure] in Arterial blood
494
2888
1.82
30.51
8.8
7.7
kpa
12.4
12.6
0.33
466
2759
(3018418) pH of Serum or Plasma
1034
7342
1.57
30.43
5.4
4.0
ph
7.4
7.4
0.16
184
1429
(3025941) Bacteria identified in Stool by Culture
287
1395
2.15
30.25
1.5
1.2
—
—
—
0
0
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
161
608
2.72
29.74
4.9
6.6
iu/ml
285.7
639.4
0.70
24
86
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
3092
27819
1.69
29.51
19.2
10.7
ml/min/173m2
87.8
85.9
4.38
2697
22863
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
1286
9639
1.51
29.29
3.5
3.0
ng/l
29.7
57.2
3.46
822
6114
(3021960) Folate [Moles/volume] in Serum or Plasma
784
5256
1.62
29.25
1.6
1.5
nmol/l
22.2
19.9
2.42
679
4583
(3015377) Calcium [Moles/volume] in Serum or Plasma
1128
8226
1.54
29.20
4.5
3.3
mmol/l
2.3
2.4
1.45
992
7355
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
854
5857
1.60
28.95
1.9
1.7
mg/l
1.3
1.1
1.00
643
4371
(3002173) Hemoglobin [Mass/volume] in Arterial blood
416
2398
1.83
26.72
9.7
8.5
g/l
121.9
125.0
2.10
403
2306
(3022217) INR in Platelet poor plasma by Coagulation assay
496
3019
1.74
26.48
24.0
22.0
inr
1.2
1.3
0.65
94
442
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
267
1328
2.09
26.45
10.8
10.1
mmol/l
23.9
24.2
1.01
245
1244
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
24
17
14.20
26.21
2.0
2.4
—
—
—
0
0
(3014007) Fractional oxyhemoglobin in Arterial blood
301
1611
1.95
24.26
10.7
9.7
%
94.2
94.1
0.05
301
1602
(3002256) Pathology report gross observation
533
3383
1.67
24.25
1.3
1.3
—
—
—
0
0
(3024354) Oxygen [Partial pressure] in Venous blood
332
1845
1.88
23.87
4.5
3.5
kpa
4.9
4.7
0.53
320
1784
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
458
2807
1.72
23.71
4.1
4.5
u/l
251.1
247.3
0.10
438
2684
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
266
1392
1.98
22.87
11.6
10.4
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
394
2338
1.77
22.83
10.5
8.0
mmol/l
10.0
9.1
1.46
381
2243
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
445
2740
1.71
22.60
1.8
1.7
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
279
1501
1.93
22.12
4.3
3.8
mmol/l
1.2
1.7
1.33
206
1103
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
290
1581
1.91
22.09
4.3
3.8
kpa
5.1
5.2
0.23
262
1480
(3000570) Elastase.pancreatic [Mass/mass] in Stool
134
537
2.55
22.02
1.5
1.4
ug/g
264.8
288.6
0.62
82
320
(3009343) pH of Capillary blood
287
1561
1.91
22.01
4.3
3.8
ph
7.4
7.4
0.84
40
192
(3007164) IgA [Mass/volume] in Serum or Plasma
726
5081
1.53
21.71
1.5
1.5
g/l
2.6
2.4
0.82
463
3296
(3000494) Fungus identified in Specimen by Culture
497
3188
1.65
21.55
1.6
1.4
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1137
8750
1.43
20.94
3.8
3.3
mmol/l
8.0
8.4
1.69
968
7518
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
443
2786
1.67
20.70
1.9
1.7
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1032
7821
1.44
20.59
2.0
2.1
u/l
213.4
273.3
1.17
973
7372
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
202
995
2.09
20.51
1.6
1.8
g/l
1.6
1.5
1.17
174
870
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
123
490
2.56
20.48
1.3
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
123
490
2.56
20.48
1.3
1.3
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
372
2241
1.73
20.36
5.5
4.1
%
0.8
0.9
0.09
110
617
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
172
798
2.21
20.34
4.6
3.9
u/ml
60.2
4953.8
0.87
159
698
(3027945) Reticulocytes/100 erythrocytes in Blood
412
2559
1.69
20.16
3.5
2.8
%
1.8
1.7
0.14
374
2304
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
2366
20701
1.40
20.13
3.8
2.9
u/l
57.9
47.6
5.58
2236
19568
(3012516) Albumin [Mass/volume] in Urine
1032
7851
1.44
20.07
3.7
3.3
mg/l
158.6
334.2
1.51
736
5184
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
194
950
2.10
20.00
2.2
2.0
ug/l
1.3
2.5
1.34
173
850
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
665
4654
1.52
19.69
1.6
1.6
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
94
339
2.82
19.04
8.7
6.1
mg/l
11.9
11.1
0.79
88
313
(3037522) Nuclear Ab [Titer] in Serum
554
3751
1.56
19.01
1.3
1.3
titre
425.6
481.5
0.31
89
734
(3020682) Albumin/Creatinine [Ratio] in Urine
1068
8246
1.42
18.91
4.6
4.0
mg/mmol
11.8
11.6
0.03
748
5471
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
692
4924
1.50
18.84
4.0
3.4
ng/l
1191.1
728.5
0.39
511
3655
(40760892) CBC W Ordered Manual Differential panel - Blood
864
6429
1.45
18.72
6.6
4.2
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
3328
31241
1.67
18.71
18.4
10.6
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
246
1342
1.89
18.67
1.8
1.6
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
147
664
2.26
18.56
1.3
1.1
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
342
2066
1.72
18.49
5.2
3.9
%
0.6
0.6
0.09
78
460
(3021440) Promyelocytes/100 leukocytes in Blood
352
2144
1.71
18.47
5.7
4.2
%
0.1
0.1
0.11
103
578
(3007566) Smooth muscle Ab [Titer] in Serum
164
779
2.16
18.31
1.2
1.3
titre
70.0
87.2
0.52
12
69
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
146
662
2.26
18.28
1.3
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
146
670
2.23
17.76
1.3
1.1
—
—
—
0
0
(3034770) Mitochondria Ab [Titer] in Serum
160
764
2.14
17.63
1.2
1.3
titre
218.0
1415.8
—
5
19
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
281
1632
1.78
17.42
5.6
4.3
ng/l
118.2
90.3
2.67
251
1447
(46235355) HIV 1 and 2 tests - Meaningful Use set
795
5898
1.44
17.32
2.1
1.9
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
597
4200
1.50
17.02
4.5
3.0
mmol/l
2.5
2.4
1.77
521
3682
(3035350) Ketones [Presence] in Urine by Test strip
1574
13121
1.35
16.87
3.6
3.1
estimate
0.0
0.0
0.80
307
2397
(3002385) Erythrocyte distribution width [Ratio]
2764
25117
1.40
16.85
25.5
14.2
%
13.8
13.5
9.99
2737
24532
(3003327) Ova and parasites identified in Stool by Light microscopy
158
765
2.11
16.81
1.8
1.7
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
578
4052
1.51
16.74
2.6
2.2
s
30.2
29.8
0.53
558
3939
(3025159) Blasts/100 leukocytes in Blood
331
2035
1.69
16.74
5.8
4.2
%
0.0
0.3
0.74
86
485
(3036481) Cortisol [Moles/volume] in Serum or Plasma
371
2350
1.64
16.73
2.4
2.3
nmol/l
374.8
366.1
0.35
335
2171
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
853
6451
1.42
16.62
2.9
2.8
ng/l
1332.8
1207.2
0.31
727
5418
(3021601) Nitrite [Presence] in Urine by Test strip
1569
13123
1.34
16.24
5.1
4.2
estimate
0.0
0.0
0.50
322
2488
(3023520) Reticulocytes [#/volume] in Blood
307
1866
1.70
16.19
3.3
2.8
e9/l
69.0
69.8
0.14
243
1401
(3026493) Urate [Moles/volume] in Serum or Plasma
949
7349
1.39
16.03
2.9
2.6
umol/l
1307.2
3843.5
2.79
832
6547
(3009261) Glucose [Presence] in Urine by Test strip
1580
13262
1.34
15.82
3.7
3.1
estimate
0.0
0.0
0.01
302
2342
(3051611) Lipemic interference index of Serum or Plasma
64
207
3.13
15.76
4.2
3.0
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
243
1393
1.80
15.74
1.6
1.4
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
157
778
2.06
15.72
3.0
3.2
u/ml
0.3
0.3
0.52
77
444
(3051651) Icteric interference index of Serum or Plasma
47
125
3.80
15.63
4.6
3.2
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
109
471
2.35
15.31
3.1
3.4
u/ml
2146.4
1438.3
—
8
34
(3005719) IgG [Mass/volume] in Serum or Plasma
335
2115
1.64
15.27
2.6
2.7
g/l
10.7
10.6
0.14
311
1933
(3028026) IgM [Mass/volume] in Serum or Plasma
271
1624
1.72
15.04
1.6
1.9
g/l
1.2
1.4
1.09
251
1508
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
190
1026
1.90
14.89
1.3
1.4
—
—
—
0
0
(3022313) Gas panel - Capillary blood
206
1144
1.85
14.80
4.6
3.8
—
—
—
0
0
(3019060) Gas panel - Arterial blood
271
1638
1.71
14.58
5.0
5.0
—
—
—
0
0
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
750
5678
1.40
14.25
1.3
1.3
u/ml
1.6
2.0
0.52
201
1566
(40768443) Skin Pathology biopsy report
191
1058
1.85
13.85
1.2
1.2
—
—
—
0
0
(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum
138
685
2.05
13.79
2.0
1.3
iu/ml
18.3
10.0
—
8
13
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
2828
26069
1.36
13.72
4.5
4.1
mu/l
2.1
2.1
0.03
2597
24102
(3037121) Protein [Mass/volume] in Urine
163
861
1.93
13.67
4.8
3.5
g/l
0.2
0.3
0.82
94
409
(3009445) Proteinase 3 Ab [Units/volume] in Serum
198
1116
1.82
13.57
1.7
1.7
u/ml
5.2
19.3
—
9
41
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
175
952
1.88
13.43
2.1
1.9
—
—
—
0
0
(4010399)
292
1854
1.62
12.99
1.4
1.4
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
179
992
1.85
12.97
5.0
4.0
mmol/l
24.3
24.8
1.51
166
937
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
388
2642
1.52
12.74
3.7
3.1
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
89
384
2.35
12.61
1.1
1.2
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
159
857
1.89
12.57
2.0
1.7
—
—
—
0
0
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
190
1091
1.78
12.27
3.2
2.9
%
0.7
0.7
0.01
184
1037
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
3351
31973
1.53
12.18
14.4
9.0
u/l
29.3
29.0
0.32
3277
30964
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
92
412
2.26
11.98
1.1
1.1
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
294
1913
1.58
11.81
2.3
2.6
g/l
66.2
67.0
0.95
273
1786
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
671
5131
1.38
11.77
1.7
1.6
pmol/l
47059238.9
36370311.0
0.15
561
4358
(3044889) 12 lead EKG panel
2230
20066
1.28
11.70
3.7
3.3
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
110
540
2.07
11.39
3.3
3.7
—
—
—
0
0
(3019225) pH of Specimen
339
2298
1.52
11.34
5.5
3.7
—
—
—
0
0
(4035726)
332
2248
1.52
11.17
1.5
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
139
755
1.87
10.78
1.1
1.1
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
751
5922
1.34
10.69
3.4
3.1
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
108
541
2.03
10.61
1.3
1.5
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
174
1017
1.75
10.60
2.6
2.3
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
174
1019
1.74
10.53
1.2
1.3
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
93
442
2.13
10.51
1.4
1.4
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
119
620
1.95
10.47
3.2
3.4
mmol/l
24.6
24.8
0.22
101
545
(3023183) Ammonium ion [Moles/volume] in Plasma
111
565
1.99
10.44
2.6
2.9
umol/l
31.7
34.8
0.98
101
499
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
35
102
3.45
10.28
2.3
3.2
—
—
—
0
0
(3041672) Baker's yeast Ab [Presence] in Serum
11
10
11.03
10.16
1.0
1.1
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
2326
21213
1.26
10.09
3.7
3.5
pmol/l
14.7
14.7
0.04
2127
19473
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
60
241
2.51
10.00
1.4
1.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
113
588
1.95
9.99
3.6
3.9
kpa
8.3
8.3
0.21
103
542
(3009542) Hematocrit [Volume Fraction] of Blood
2997
28237
1.33
9.96
22.5
12.4
%
40.7
41.0
1.23
2273
21892
(3005988) Vibrio sp identified in Specimen by Organism specific culture
59
236
2.52
9.92
1.4
1.5
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
59
238
2.50
9.76
1.4
1.5
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
151
869
1.77
9.73
2.3
2.5
ug/l
505.2
602.3
0.20
145
822
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
104
532
1.98
9.67
4.6
3.8
%
58.5
57.2
0.46
104
532
(3004119) Hemoglobin [Mass/volume] in Venous blood
228
1466
1.59
9.66
3.8
3.4
g/l
127.8
132.7
2.32
219
1433
(3025468) Yersinia sp identified in Specimen by Organism specific culture
58
234
2.50
9.59
1.4
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
59
240
2.48
9.59
1.4
1.5
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
145
829
1.78
9.56
3.2
2.8
g/l
3.8
3.5
1.17
140
793
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
583
4501
1.35
9.46
2.0
1.8
%
1.5
1.4
1.59
513
4036
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
92
454
2.05
9.45
1.5
1.7
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
58
236
2.48
9.43
1.4
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
116
624
1.89
9.31
1.2
1.3
u/ml
296.4
254.7
0.79
70
391
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
700
5570
1.32
9.21
1.6
1.5
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
2251
20558
1.24
9.15
3.2
3.0
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
119
654
1.85
8.95
1.2
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
81
391
2.10
8.85
2.6
3.4
%
1.3
1.1
0.22
60
306
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
123
687
1.82
8.79
1.2
1.3
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
2851
26803
1.28
8.79
6.5
5.1
mmol/mol
41.3
39.4
14.93
2672
25163
(3007461) Platelets [#/volume] in Blood
3484
33793
1.57
8.75
30.8
16.8
e9/l
255.6
248.6
7.53
3432
32956
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
58
245
2.39
8.73
1.2
1.4
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
102
538
1.92
8.72
2.5
2.2
g/l
131.3
133.3
0.33
77
396
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
151
900
1.71
8.64
1.6
1.6
titre
176.7
431.5
—
6
33
(3008152) Bicarbonate [Moles/volume] in Arterial blood
237
1578
1.54
8.63
7.9
7.3
mmol/l
24.4
24.6
0.44
220
1471
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
316
2233
1.45
8.60
3.4
2.5
ml/min/173m2
71.1
71.5
0.04
144
803
(3024980) IgG subclass 4 [Mass/volume] in Serum
90
457
1.99
8.59
1.5
1.7
g/l
0.7
0.9
0.97
70
342
(3021879) Hepatitis B virus core Ab [Presence] in Serum
344
2472
1.43
8.56
1.6
1.5
—
—
—
0
0
(3024731) MCV [Entitic volume]
3485
33827
1.56
8.46
30.7
16.7
fl
90.7
90.6
0.87
3466
33376
(3014271) Vancomycin [Susceptibility]
27
76
3.57
8.39
2.7
2.6
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
94
489
1.95
8.38
1.6
1.6
—
—
—
0
0
(1616796) Gas panel - Central venous blood
106
574
1.87
8.38
3.7
3.8
—
—
—
0
0
(3026361) Erythrocytes [#/volume] in Blood
3485
33834
1.55
8.37
30.7
16.8
e12/l
4.5
4.6
12.65
3422
32920
(3000963) Hemoglobin [Mass/volume] in Blood
3486
33847
1.55
8.35
30.9
16.9
g/l
136.5
139.5
22.80
3466
33386
(3010813) Leukocytes [#/volume] in Blood
3486
33848
1.55
8.34
30.8
16.8
e9/l
7.2
6.7
23.58
3424
32932
(3035941) MCH [Entitic mass]
3484
33828
1.55
8.29
30.6
16.7
pg
30.2
30.3
2.57
3465
33375
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
53
221
2.42
8.22
1.2
1.2
titre
71.8
224.0
1.82
11
45
(3008757) Leukocyte morphology finding [Identifier] in Blood
57
246
2.34
8.20
2.6
4.1
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
541
4222
1.33
8.10
1.3
1.2
u/ml
13.5
12.0
0.17
211
1718
(3013512) EKG study
866
7194
1.27
8.04
4.2
3.3
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
86
442
1.97
7.96
3.4
2.8
—
—
—
0
0
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
565
4452
1.32
7.89
1.3
1.2
iu/ml
26.9
31.3
0.45
162
1382
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
32
106
3.04
7.72
2.8
1.8
umol/l
27.4
28.5
0.26
32
100
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
115
656
1.78
7.71
1.3
2.0
g/l
37.2
38.1
0.89
103
585
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
71
346
2.07
7.62
1.2
1.2
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
52
225
2.33
7.47
1.3
1.4
e6/l
54120.9
69714.8
0.15
34
127
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
34
120
2.85
7.36
1.2
1.1
iu/ml
231.8
193.9
0.24
34
120
(3049717) Cytology report of Urine Cyto stain
147
911
1.64
7.30
2.6
2.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
71
353
2.03
7.24
1.5
1.3
mmol/l
64.1
68.5
0.30
44
292
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
163
1040
1.59
7.20
5.1
3.7
%
53.2
49.0
1.25
158
1024
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
447
3458
1.33
7.07
2.3
1.9
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
13
23
5.67
7.06
1.0
1.4
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
131
799
1.66
6.94
2.4
2.6
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
109
633
1.74
6.91
1.6
1.5
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
975
8334
1.23
6.86
1.5
1.4
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
223
1542
1.47
6.82
1.7
2.3
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
54
248
2.19
6.78
1.8
2.2
mg/l
21.8
20.6
0.09
16
70
(3012501) Base excess in Blood by calculation
105
607
1.75
6.77
3.8
3.9
mmol/l
3.2
2.4
1.06
71
396
(3027456) Digoxin [Moles/volume] in Serum or Plasma
67
335
2.02
6.75
2.4
2.9
nmol/l
0.9
0.8
0.76
50
270
(3004716) Salmonella sp identified in Stool by Organism specific culture
199
1350
1.50
6.70
1.5
1.4
—
—
—
0
0
(3029634) Reagin Ab [Titer] in Serum by VDRL
87
477
1.84
6.69
3.0
2.1
titre
27.6
12.5
—
5
14
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
120
724
1.68
6.64
1.3
2.3
g/l
1.3
1.0
0.16
109
639
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
133
827
1.63
6.56
3.2
2.6
%
204.9
181.5
2.20
128
790
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
126
776
1.65
6.46
1.2
2.3
g/l
10.7
10.4
0.17
111
673
(3023199) Leukocytes [#/volume] in Pleural fluid
54
254
2.14
6.41
1.3
1.4
e6/l
2282.2
1876.6
0.33
39
174
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
128
794
1.63
6.38
1.2
2.2
g/l
3.2
3.0
1.01
108
642
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
102
596
1.73
6.36
1.3
2.1
g/l
0.0
0.0
0.00
97
561
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
128
795
1.63
6.35
4.2
4.5
mg/l
1.7
1.4
1.98
120
739
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
265
1919
1.41
6.35
2.8
2.7
ng/l
202.3
163.4
0.74
235
1731
(21494815) CD4 cells/100 lymphocytes in Specimen
56
269
2.10
6.31
2.2
2.6
%
54.1
40.0
—
8
34
(3011985) Renin [Units/volume] in Plasma
67
344
1.97
6.30
1.2
1.4
mu/l
62.3
62.9
0.01
59
310
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
57
276
2.08
6.29
1.3
1.3
nmol/l
1.5
1.4
0.17
52
248
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
132
833
1.61
6.15
1.2
2.2
g/l
3.9
3.9
0.07
106
627
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
132
833
1.61
6.15
1.2
2.2
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
132
833
1.61
6.15
1.2
2.2
g/l
7.5
7.3
0.86
111
654
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
49
226
2.18
6.12
1.3
1.5
—
—
—
0
0
(3010421) pH of Blood
115
702
1.66
6.12
3.8
4.0
ph
7.4
7.4
0.11
103
597
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
480
3825
1.29
6.11
2.5
2.0
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
867
7397
1.23
6.11
3.5
2.7
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
34
133
2.57
6.11
2.8
2.7
u/ml
1150.6
834.0
0.60
34
133
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
102
604
1.71
6.08
1.3
2.1
g/l
0.0
0.0
0.00
97
561
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
108
650
1.68
6.07
1.3
2.1
g/l
0.0
0.0
0.09
103
606
(3027273) Bicarbonate [Moles/volume] in Venous blood
166
1110
1.52
6.01
4.8
3.4
mmol/l
24.8
25.3
0.86
158
1081
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
260
1898
1.40
5.96
2.4
2.0
—
—
—
0
0
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
152
1000
1.54
5.94
6.4
5.4
%
2.0
1.7
1.32
142
928
(3003434) Protein [Mass/volume] in Pleural fluid
58
290
2.02
5.89
1.5
1.5
g/l
33.4
33.5
0.02
53
265
(3010375) cycloSPORINE [Mass/volume] in Blood
36
148
2.45
5.85
27.3
25.1
ug/l
137.5
125.5
0.46
26
124
(3020891) Body temperature
152
1006
1.53
5.79
5.6
4.6
—
—
—
0
0
(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma
32
125
2.57
5.78
1.2
1.1
u/l
16.4
18.1
0.10
26
101
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
23
75
3.08
5.76
2.0
2.6
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
110
679
1.64
5.64
1.4
1.4
—
—
—
0
0
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
107
656
1.65
5.63
2.2
3.7
mg/l
37.3
50.5
0.68
83
532
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
48
228
2.12
5.60
2.1
2.8
e6/l
595.4
679.0
0.43
20
88
(40768441) Liver Pathology biopsy report
43
196
2.21
5.56
1.5
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
107
659
1.64
5.54
1.4
1.7
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
148
984
1.53
5.53
1.4
1.4
u/l
10.1
7.7
1.22
120
792
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
56
284
1.99
5.50
1.3
1.6
%
59.0
57.5
0.09
39
175
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
33
135
2.46
5.44
1.3
1.2
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
142
940
1.53
5.42
3.1
2.4
%
88.5
91.8
1.02
137
881
(3034860) Kappa light chains.free [Mass/volume] in Serum
106
656
1.63
5.39
2.2
3.7
mg/l
52.1
53.7
0.07
82
528
(3023323) Follitropin [Units/volume] in Serum or Plasma
179
1248
1.46
5.32
1.4
1.4
iu/l
25.0
25.3
0.04
146
1056
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
33
137
2.42
5.29
1.3
1.2
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
208
1494
1.42
5.26
2.4
2.0
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
36
156
2.32
5.25
2.4
1.8
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
47
228
2.08
5.22
1.3
1.5
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1163
10327
1.18
5.21
3.9
3.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
48
235
2.06
5.20
2.8
3.5
%
60.6
56.9
0.60
29
153
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
43
202
2.14
5.19
1.9
3.0
e6/l
420.9
511.9
0.79
33
175
(3045788) Cell count panel - Pleural fluid
44
209
2.12
5.16
1.3
1.5
—
—
—
0
0
(40761535) Cells panel - Urine sediment
268
2017
1.35
5.12
3.9
3.2
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
29
115
2.53
5.12
3.9
4.5
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
273
2061
1.35
5.11
1.2
1.2
—
—
—
0
0
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
47
230
2.06
5.11
1.1
1.1
u/l
66.9
61.0
0.25
33
157
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
104
651
1.61
5.08
1.4
1.8
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
294
2248
1.33
5.06
4.0
3.4
—
—
—
0
0
(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination
73
416
1.77
5.04
2.5
1.9
titre
7085.7
1360.0
—
7
19
(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma
31
128
2.43
5.04
1.2
1.1
u/l
75.2
87.0
0.23
25
106
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
96
591
1.64
5.01
1.6
1.5
u/ml
114.3
113.1
0.03
21
109
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
23
82
2.82
4.97
1.3
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
23
82
2.82
4.97
1.3
1.4
—
—
—
0
0
(3028271) Lactate [Moles/volume] in Capillary blood
73
418
1.76
4.97
2.2
1.8
mmol/l
1.6
1.7
0.46
73
409
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
390
3108
1.28
4.96
4.6
4.1
%
31.1
31.0
0.03
279
2196
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
81
478
1.71
4.96
1.3
1.8
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
54
282
1.93
4.91
1.8
2.8
e9/l
1.1
1.2
0.12
25
171
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
123
808
1.54
4.90
1.5
1.6
g/l
1.2
1.2
0.32
115
770
(3008536) Aspergillus sp Ab [Presence] in Serum
18
56
3.23
4.89
2.3
2.7
—
—
—
0
0
(3007930) Methemoglobin/Hemoglobin.total in Blood
145
988
1.49
4.87
6.6
5.4
%
0.9
0.9
0.14
134
920
(3036489) Thrombin time
155
1072
1.47
4.83
3.0
2.2
s
21.2
21.3
0.05
145
930
(3024471) HLA-A [Type]
29
120
2.43
4.71
1.0
1.0
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
101
641
1.59
4.69
2.3
3.6
ratio
2.8
4.1
0.22
12
61
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
118
777
1.54
4.67
1.5
1.6
g/l
0.3
0.2
0.59
109
743
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
45
225
2.01
4.65
3.1
4.1
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
41
198
2.08
4.64
1.8
3.1
e9/l
0.1
0.2
2.93
33
175
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
20
69
2.91
4.60
1.9
1.4
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
39
186
2.11
4.57
1.2
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
116
765
1.53
4.57
4.7
4.4
mmol/l
3.9
3.9
0.09
110
722
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
271
2082
1.33
4.54
2.2
2.2
ug/l
9.6
9.1
0.08
235
1893
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
135
921
1.48
4.53
1.6
1.7
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
81
491
1.66
4.53
1.1
1.2
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
27
111
2.44
4.46
2.0
1.7
—
—
—
0
0
(3047181) Lactate [Moles/volume] in Blood
119
794
1.52
4.45
6.8
6.3
mmol/l
1.3
1.3
0.28
102
695
(40760888) Immunoglobulin light chains.free panel - Serum
83
509
1.65
4.44
2.4
3.8
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
43
216
2.00
4.40
4.6
2.4
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
59
332
1.79
4.30
1.2
1.4
pmol/l
242.3
286.6
0.81
44
253
(40767503) Oxygen content in Capillary blood by calculation
88
554
1.60
4.26
3.1
2.3
%
16.3
16.8
0.54
53
267
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
77
469
1.66
4.25
3.7
3.6
u/ml
941.9
722.2
0.09
70
438
(3000093) Morphology [Interpretation] in Blood Narrative
45
233
1.94
4.24
1.1
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
17
56
3.05
4.23
2.9
6.9
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
57
320
1.79
4.20
1.8
2.4
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
100
652
1.55
4.17
2.3
1.8
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
174
1265
1.39
4.17
1.1
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
60
343
1.76
4.16
1.1
1.1
—
—
—
0
0
(4146454)
47
249
1.90
4.15
2.7
2.7
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
22
86
2.57
4.04
1.0
1.2
—
—
—
0
0
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
229
1749
1.33
4.02
1.2
1.3
au/ml
52.9
54.4
—
5
78
(3021788) Differential panel - Synovial fluid
72
438
1.66
4.01
1.5
1.6
—
—
—
0
0
(3040893) Potassium [Moles/volume] in Capillary blood
7
7
10.02
4.01
2.4
2.0
mmol/l
4.1
4.6
—
7
7
(3017732) Neutrophils [#/volume] in Blood
245
1891
1.32
4.00
2.8
2.7
e9/l
4.5
4.2
0.84
186
1559
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
26
111
2.35
3.99
2.6
3.1
—
—
—
0
0
(3024932) HLA-DR beta [Type]
27
118
2.30
3.94
1.1
1.1
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
91
595
1.54
3.79
1.6
1.7
e6/l
15923.0
12430.0
0.28
60
425
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
65
392
1.67
3.76
1.1
1.1
g/l
1.4
1.5
0.37
56
354
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
28
127
2.21
3.76
1.6
1.8
nmol/l
7.7
4.2
0.34
22
104
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
8
12
6.68
3.67
9.0
4.8
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
42
225
1.88
3.63
1.2
1.8
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
42
225
1.88
3.63
1.2
1.8
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
42
225
1.88
3.63
1.2
1.8
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
19
74
2.58
3.54
1.4
1.2
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
256
2023
1.29
3.54
4.7
3.9
mmol/l
1.2
1.2
0.25
230
1759
(3042631) Mycobacterium sp identified in Specimen
57
338
1.70
3.53
2.1
2.8
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
91
605
1.52
3.53
1.5
1.6
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
30
144
2.09
3.52
1.6
1.3
u/ml
20.1
20.3
—
7
29
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
26
118
2.21
3.50
1.2
2.3
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
26
118
2.21
3.50
1.2
2.3
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
26
118
2.21
3.50
1.2
2.3
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
26
118
2.21
3.50
1.2
2.3
—
—
—
0
0
(3030408) 3-Methoxytyramine [Moles/volume] in Serum or Plasma
57
339
1.69
3.50
1.3
1.3
nmol/l
0.1
0.3
—
8
23
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
25
112
2.24
3.47
1.3
1.3
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
16
58
2.77
3.42
1.4
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
51
297
1.73
3.39
1.2
1.8
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
792
7028
1.16
3.38
4.2
3.4
estimate
0.0
0.0
2.17
301
2353
(3026389) Candida sp identified in Specimen by Organism specific culture
53
313
1.70
3.35
1.3
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
382
3182
1.22
3.35
8.6
5.9
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
36
189
1.91
3.33
2.5
3.0
%
48.7
40.9
—
5
60
(3035880) pH of Pleural fluid
26
121
2.16
3.31
1.3
1.4
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
21
89
2.37
3.31
1.1
2.7
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
21
89
2.37
3.31
1.1
2.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
21
89
2.37
3.31
1.1
2.7
—
—
—
0
0
(3039000) Anion gap in Blood
87
583
1.50
3.28
7.7
7.2
mmol/l
12.1
11.5
0.98
79
520
(4268621)
54
323
1.68
3.27
2.0
2.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
87
584
1.50
3.26
7.7
7.2
mmol/l
105.1
105.2
0.09
79
521
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
21
90
2.34
3.24
2.0
3.5
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
24
110
2.19
3.18
1.3
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
24
110
2.19
3.18
1.7
2.0
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
24
110
2.19
3.18
1.7
2.0
—
—
—
0
0
(3000492) Spirometry study
366
3052
1.22
3.18
1.4
1.4
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
49
288
1.71
3.17
1.3
1.3
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
23
104
2.22
3.15
1.2
1.1
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
53
319
1.67
3.15
1.4
1.7
—
—
—
0
0
(3008898) HLA-B27 [Presence]
142
1052
1.36
3.12
1.1
1.1
—
—
—
0
0
(3003338) MCHC [Mass/volume]
2747
26508
1.14
3.10
26.8
14.6
g/l
332.8
334.1
10.06
2733
26299
(3023511) Choriogonadotropin [Units/volume] in Urine
72
470
1.54
3.08
1.5
1.3
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
47
276
1.71
3.06
1.1
1.9
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
42
239
1.77
3.05
1.6
1.6
—
—
—
0
0
(3027135) IgG subclass 1 [Mass/volume] in Serum
48
284
1.70
3.05
1.3
1.3
g/l
6.3
6.8
0.60
35
191
(3028192) IgG subclass 2 [Mass/volume] in Serum
48
284
1.70
3.05
1.3
1.3
g/l
3.4
3.1
0.49
35
191
(3024139) IgG subclass 3 [Mass/volume] in Serum
48
284
1.70
3.05
1.3
1.3
g/l
0.4
0.4
0.34
35
190
(3028717) Thiamine [Mass/volume] in Blood
10
29
3.45
3.04
1.5
1.3
—
—
—
0
0
(4062490)
48
285
1.69
3.01
1.3
1.3
—
—
—
0
0
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
238
1906
1.27
3.00
2.3
2.3
au/ml
14.7
23.4
1.07
13
119
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
17
69
2.47
2.95
2.1
1.8
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
96
672
1.44
2.94
2.9
2.4
ug/min
182.7
125.6
0.35
62
439
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
93
648
1.45
2.93
1.3
1.4
mmol/l
3.7
3.8
0.13
87
605
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
8
17
4.71
2.91
1.3
4.7
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
8
17
4.71
2.91
1.3
4.4
—
—
—
0
0
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
12
41
2.93
2.85
1.5
1.2
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
41
237
1.74
2.84
2.8
2.1
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
103
737
1.41
2.82
1.4
1.4
mg/l
604.3
531.9
0.52
97
698
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
68
449
1.52
2.80
1.2
1.3
u/l
20.7
47.3
1.96
58
388
(3005322) IgE [Units/volume] in Serum or Plasma
222
1780
1.26
2.79
1.3
1.3
u/ml
216.8
248.5
0.30
204
1650
(3035285) Chloride [Moles/volume] in Venous blood
42
247
1.71
2.75
2.7
2.1
mmol/l
104.7
105.7
0.51
42
242
(3041354) Potassium [Moles/volume] in Venous blood
42
247
1.71
2.75
2.7
2.1
mmol/l
3.9
4.1
1.92
42
242
(21494755) Public health laboratory ask at order entry panel
340
4021
0.83
2.74
1.3
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
2908
28238
1.14
2.73
4.6
4.0
mmol/l
6.2
5.9
11.57
2668
26123
(3000060) B lymphocytes [#/volume] in Blood
20
91
2.20
2.73
1.8
2.8
e6/l
245.5
165.6
0.27
11
50
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
69
460
1.51
2.72
1.1
1.2
u/ml
2.7
4.6
1.47
30
198
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
11
37
2.98
2.69
1.0
1.1
—
—
—
0
0
(44806118)
53
334
1.60
2.68
1.5
1.5
—
—
—
0
0
(44790049)
53
334
1.60
2.68
1.5
1.5
—
—
—
0
0
(44790048)
53
334
1.60
2.68
1.5
1.5
—
—
—
0
0
(44790047)
53
334
1.60
2.68
1.5
1.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
10
32
3.13
2.64
4.0
2.2
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
41
243
1.69
2.63
1.4
1.4
%
33.4
30.9
0.14
28
152
(3008295) Osmolality of Serum or Plasma
42
251
1.68
2.61
1.4
1.4
mosm/kgh2o
282.6
281.1
0.15
28
197
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
92
655
1.41
2.61
1.4
1.5
e6/l
20.3
24.1
0.12
72
499
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
92
655
1.41
2.61
1.5
1.6
e6/l
1461.8
1379.9
0.03
74
530
(3008116) Ketones [Moles/volume] in Urine by Test strip
14
55
2.55
2.61
1.8
1.3
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
71
482
1.48
2.59
1.3
1.5
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
50
314
1.60
2.58
1.6
1.6
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
61
402
1.53
2.56
1.4
1.5
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
60
394
1.53
2.56
1.4
1.6
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
32
178
1.80
2.55
2.2
2.1
—
—
—
0
0
(3025315) Body weight
7
16
4.38
2.47
5.9
2.1
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
372
3188
1.19
2.46
2.4
2.2
nmol/l
12.9
13.6
1.05
332
2893
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
76
529
1.45
2.46
1.1
1.1
iu/ml
9.5
1050.5
0.58
13
133
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
74
514
1.45
2.42
1.2
1.2
u/ml
5.8
5.9
—
7
36
(44816559) Phosphatidylethanol [Mass/volume] in Blood
92
665
1.39
2.42
1.5
1.5
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
24
124
1.94
2.40
1.5
2.4
umol/l
106.1
172.7
0.60
11
67
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
108
803
1.36
2.40
1.3
1.3
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
142
1099
1.30
2.40
1.7
1.6
mu/l
304.3
293.6
0.12
134
996
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
68
466
1.47
2.39
1.1
1.1
au/ml
16.6
9.0
—
7
34
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
15
64
2.35
2.38
1.9
2.4
umol/l
15.2
16.5
0.13
15
64
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
156
1225
1.29
2.36
1.8
1.9
u/l
39.3
38.9
0.08
140
1093
(3032743) Legionella sp IgG Ab [Presence] in Serum
7
17
4.12
2.36
1.0
1.1
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
76
534
1.43
2.35
1.1
1.1
—
—
—
0
0
(3009466) Valproate [Moles/volume] in Serum or Plasma
72
501
1.45
2.35
4.5
5.2
umol/l
355.0
370.6
0.40
65
437
(3023410) Appearance of Cerebral spinal fluid
46
291
1.59
2.33
1.8
1.9
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
62
420
1.48
2.32
4.3
3.6
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
39
237
1.65
2.31
1.1
1.4
e6/l
144790.4
107918.5
0.14
27
169
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
32
184
1.75
2.31
1.2
1.2
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
32
184
1.75
2.31
1.2
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
32
184
1.75
2.31
1.2
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
28
3.22
2.30
1.0
1.3
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
51
332
1.54
2.29
1.1
1.1
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
11
41
2.69
2.27
1.0
1.0
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
55
365
1.51
2.27
1.7
1.5
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
49
317
1.55
2.27
1.2
1.6
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
35
208
1.69
2.26
1.7
2.4
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
7
18
3.89
2.25
1.0
1.1
—
—
—
0
0
(21494434) Karyotype in Bone marrow
36
216
1.67
2.25
1.4
1.2
—
—
—
0
0
(44813793)
31
179
1.74
2.22
1.0
1.0
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
637
5730
1.14
2.21
4.1
3.4
kg/l
1.0
1.0
0.27
81
758
(4034850)
118
902
1.32
2.20
8.4
8.8
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
32
187
1.72
2.20
1.2
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
32
187
1.72
2.20
1.2
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
32
187
1.72
2.20
1.2
1.1
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
10
36
2.78
2.20
8.4
11.0
mmol/l
6.2
6.5
—
10
36
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
35
210
1.67
2.19
1.3
1.2
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
44
281
1.57
2.16
1.5
1.4
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
129
1002
1.30
2.15
1.2
1.2
u/ml
0.3
1.1
1.43
16
81
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
823
7531
1.12
2.15
1.8
1.7
mmol/l
1.6
1.4
2.70
710
6428
(3030313) Adrenal Ab [Titer] in Serum
7
19
3.69
2.15
1.0
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
29
166
1.75
2.15
1.1
1.1
nmol/l
1.0
4.4
—
8
36
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
34
204
1.67
2.14
1.1
1.0
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
35
212
1.66
2.13
1.1
1.1
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
78
563
1.39
2.11
1.1
1.1
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
34
205
1.66
2.10
1.1
1.0
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
38
236
1.62
2.10
1.1
1.4
mmol/l
13.2
11.3
0.80
19
70
(1761868) Lipid panel - Serum or Plasma
1122
12012
0.91
2.08
2.7
2.6
—
—
—
0
0
(3039162) Centromere protein B Ab [Units/volume] in Serum
46
300
1.54
2.08
1.2
1.3
u/ml
31.5
42.9
—
5
15
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
5
10
5.01
2.07
1.0
1.2
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
23
124
1.86
2.06
1.2
1.2
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
24
133
1.81
1.99
1.5
1.6
u/field
3.5
3.7
0.04
18
101
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
56
385
1.46
1.99
1.3
1.5
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
47
312
1.51
1.98
1.3
1.3
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
36
225
1.61
1.96
1.6
2.5
%
10.6
13.6
1.00
19
106
(3003740) Influenza virus B Ag [Presence] in Specimen
77
564
1.37
1.94
1.1
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
37
570
0.65
1.92
1.4
1.6
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
62
440
1.42
1.88
1.3
1.3
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
85
637
1.34
1.86
1.3
1.3
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
33
205
1.62
1.85
1.3
1.3
—
—
—
0
0
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
6
17
3.53
1.83
1.0
1.3
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
12
53
2.27
1.80
1.3
1.4
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
104
808
1.30
1.78
1.6
1.8
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
337
2950
1.16
1.77
1.8
1.7
—
—
—
0
0
(3001186) Copper [Moles/volume] in Serum or Plasma
14
67
2.09
1.75
1.5
1.1
umol/l
15.7
17.3
0.71
14
59
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
6
18
3.34
1.74
1.0
1.3
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
44
297
1.49
1.74
1.3
1.3
nmol/l
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
100
776
1.30
1.74
1.2
1.1
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
21
117
1.80
1.74
1.5
1.3
%
3.3
4.4
—
6
25
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
120
954
1.27
1.73
3.0
2.5
u/l
5512.4
4905.6
0.08
35
371
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
164
1351
1.22
1.72
1.7
1.8
nmol/l
37.8
38.6
0.15
157
1314
(3044009) aPTT.lupus sensitive (LA screen)
8
30
2.67
1.72
1.3
1.2
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
11
230
0.48
1.71
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
389
3449
1.14
1.71
1.5
1.4
—
—
—
0
0
(3004451) EKG impression Narrative
21
118
1.78
1.70
1.1
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
57
786
0.72
1.69
1.4
1.4
—
—
—
0
0
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
100
780
1.29
1.68
2.1
2.0
mg/l
11.1
10.6
0.24
95
731
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
13
62
2.10
1.65
1.2
1.1
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
7
25
2.80
1.65
1.0
1.1
—
—
—
0
0
(3033799) Differential panel - Peritoneal fluid
15
76
1.98
1.64
1.7
2.0
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
64
470
1.37
1.63
1.1
1.2
u/ml
2.2
3.5
0.83
25
153
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
31
197
1.58
1.62
1.5
1.6
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
34
221
1.54
1.62
1.2
1.1
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
86
662
1.31
1.61
1.3
1.2
u/ml
5.6
8.9
0.44
14
99
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
20
113
1.77
1.60
1.3
1.1
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
85
654
1.31
1.60
1.3
1.2
u/ml
6.2
3.0
—
8
66
(3043410) Blood group antigens tested for on Red Blood Cells
14
70
2.00
1.59
2.0
1.4
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
60
440
1.37
1.55
1.4
1.8
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
58
423
1.38
1.55
1.3
1.4
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
26
160
1.63
1.55
2.7
2.6
%
97.2
95.9
0.08
26
153
(3019977) pH of Arterial blood
21
122
1.73
1.54
1.3
2.7
ph
7.4
7.4
—
7
43
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
51
365
1.40
1.53
1.2
1.5
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
6
21
2.86
1.50
1.5
2.0
—
—
—
0
0
(3037692) Legionella sp identified in Specimen by Organism specific culture
16
86
1.86
1.50
1.0
1.4
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
22
131
1.68
1.49
1.1
1.2
nmol/l
144.6
138.5
0.27
22
131
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
36
524
0.68
1.48
1.6
1.7
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
48
342
1.41
1.48
1.3
1.2
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
102
1271
0.80
1.48
2.0
1.8
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
90
708
1.28
1.46
1.3
1.2
u/ml
6.2
41.1
—
7
41
(3027923) C peptide [Moles/volume] in Serum or Plasma
27
171
1.58
1.45
1.3
1.4
nmol/l
0.9
1.3
2.05
22
135
(3013139) Helicobacter pylori Ag [Presence] in Stool
186
1581
1.19
1.45
1.2
1.2
—
—
—
0
0
(3013762) Body weight Measured
5
16
3.13
1.44
1.0
1.3
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
5
16
3.13
1.44
1.0
1.1
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
99
1232
0.80
1.43
1.3
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
21
125
1.68
1.43
1.7
1.9
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
21
125
1.68
1.43
1.9
1.7
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
9
39
2.31
1.43
1.1
1.0
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
19
110
1.73
1.42
1.3
1.1
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
20
118
1.70
1.41
1.4
2.3
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
41
287
1.43
1.40
1.1
1.1
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
9
40
2.25
1.40
3.0
2.7
ml/dl
14.0
15.4
—
9
35
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
29
2.42
1.39
1.0
1.1
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
19
111
1.72
1.39
1.8
2.6
—
—
—
0
0
(3009613) Erythrocytes [#/volume] in Peritoneal fluid
14
74
1.90
1.39
1.7
1.8
e6/l
418.0
27698.9
—
6
41
(3026480) Teichoate Ab [Titer] in Serum
6
23
2.61
1.36
1.0
1.1
—
—
—
0
0
(3027570) Oxalate [Moles/time] in 24 hour Urine
5
17
2.94
1.36
1.4
1.4
umol/24h
406.0
332.4
—
5
17
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
5
17
2.94
1.36
4.4
6.9
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
5
17
2.94
1.36
4.8
2.5
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
0
38
0.00
1.34
0.0
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
80
628
1.28
1.34
2.6
2.2
nmol/l
0.8
0.8
0.10
67
525
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
9
42
2.15
1.33
1.9
1.6
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
37
257
1.44
1.33
2.2
2.2
nmol/l
20.9
19.6
0.33
32
243
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
18
105
1.72
1.33
1.0
1.0
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
54
402
1.35
1.31
1.2
1.1
u/ml
3.0
3.5
0.17
28
214
(3042517) Benzodiazepines panel - Urine
9
43
2.10
1.30
8.0
2.3
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
45
326
1.39
1.30
1.1
1.1
—
—
—
0
0
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
5
18
2.78
1.28
1.6
1.7
mg/l
0.7
1.5
—
5
12
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
5
18
2.78
1.28
1.6
1.7
mg/l
0.8
1.8
—
5
13
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
12
62
1.94
1.27
1.4
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
68
527
1.30
1.27
1.1
1.1
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
36
252
1.43
1.26
1.5
1.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
3063
30157
1.09
1.25
4.9
4.4
mmol/l
2.7
2.8
7.94
2848
28240
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
8
36
2.22
1.24
1.0
1.3
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
25
163
1.54
1.23
1.2
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
55
416
1.33
1.22
2.6
1.7
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
84
673
1.25
1.21
5.9
3.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
19
2.63
1.21
1.6
2.0
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
5
19
2.63
1.21
1.6
1.8
mg/l
0.9
1.8
—
5
14
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
89
718
1.25
1.21
1.2
1.1
u/ml
8.4
7.2
0.09
19
104
(3029075) Extractable nuclear Ab panel - Serum
14
78
1.80
1.21
1.2
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
27
180
1.50
1.20
1.1
1.2
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
135
1138
1.19
1.20
1.7
1.8
—
—
—
0
0
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
33
230
1.44
1.19
1.1
1.0
mg/l
315.3
285.7
0.46
28
208
(3018461) Alpha 1 globulin [Mass/time] in 24 hour Urine by Electrophoresis
8
38
2.11
1.18
8.0
5.9
ug/min
22.9
46.2
—
8
33
(1617658) Protocol used for examination of sentinel lymph nodes
9
170
0.53
1.18
1.0
1.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
20
125
1.60
1.17
6.4
2.5
mmol/l
8.3
9.8
1.01
14
93
(44817194) Complement alternate pathway AH50 actual/normal in Serum by Immunoassay
10
50
2.00
1.16
1.1
1.1
%
96.9
91.6
—
10
50
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
10
50
2.00
1.16
1.1
1.1
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
50
377
1.33
1.15
1.3
1.4
u/l
30.7
24.0
0.57
38
312
(3029493) Herpes virus 6 DNA [Presence] in Blood by NAA with probe detection
5
20
2.50
1.15
2.6
3.9
—
—
—
0
0
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
18
284
0.63
1.14
1.1
1.2
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
112
0.45
1.12
1.2
1.0
—
—
—
0
0
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
23
151
1.53
1.11
1.6
1.9
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
13
73
1.78
1.10
2.2
1.5
—
—
—
0
0
(3020876) Protein [Mass/time] in 24 hour Urine
30
210
1.43
1.08
2.2
2.1
—
1.4
—
0
16
(3019174) dRVVT (LA screen)
7
32
2.19
1.08
1.3
1.3
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
67
532
1.26
1.07
5.4
3.4
—
—
—
0
0
(43055514) Macroprolactin [Presence] in Serum or Plasma
13
74
1.76
1.06
1.3
1.5
—
—
—
0
0
(4306422)
59
462
1.28
1.06
1.2
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
145
1.52
1.05
1.0
1.2
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
32
442
0.72
1.05
1.3
1.5
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
18
113
1.60
1.05
2.7
4.2
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
60
472
1.28
1.04
1.1
1.1
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
30
212
1.42
1.03
1.3
1.6
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
45
341
1.32
1.03
1.2
1.2
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
21
138
1.52
1.02
1.0
1.2
miu/ml
1596.8
1552.6
0.07
21
138
(3052592) Norovirus Ag [Presence] in Stool
7
35
2.00
1.00
1.9
1.5
—
—
—
0
0
(4281824)
28
197
1.42
0.99
1.3
1.1
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
25
172
1.46
0.99
1.1
1.6
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
174
1527
1.15
0.98
3.7
2.3
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
9
49
1.84
0.98
1.6
2.9
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
11
61
1.81
0.98
1.2
1.0
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
41
309
1.33
0.98
1.8
1.8
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
14
84
1.67
0.97
1.8
1.3
—
—
—
0
0
(3045424) Erythrocytes [Presence] in Urine
57
451
1.27
0.96
1.5
1.5
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
17
108
1.58
0.96
1.1
1.1
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
22
149
1.48
0.95
1.9
1.5
u/l
10.4
5.6
0.55
15
76
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
22
149
1.48
0.95
1.0
1.2
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
2902
28597
1.07
0.94
4.1
3.7
mmol/l
1.5
1.3
13.68
2676
26725
(1001926) Buprenorphine [Presence] in Urine by Screen method
146
1271
1.15
0.93
3.8
2.3
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
23
158
1.46
0.93
1.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
22
151
1.46
0.90
1.1
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
29
2.07
0.89
1.0
1.0
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
6
29
2.07
0.89
1.2
1.1
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
28
202
1.39
0.89
1.2
1.1
—
—
—
0
0
(3003171) Aldosterone [Moles/volume] in Serum or Plasma --upright
10
56
1.79
0.87
1.4
1.2
pmol/l
293.4
267.3
—
5
44
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
6
30
2.00
0.87
1.2
1.4
—
—
—
0
0
(1002224) Polysomnography panel
174
1544
1.13
0.86
1.1
1.1
—
—
—
0
0
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
50
396
1.27
0.86
1.2
1.5
nmol/l
0.3
0.4
0.87
37
309
(3000330) Specific gravity of Urine by Test strip
128
1112
1.16
0.86
4.3
2.9
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
29
212
1.37
0.86
1.3
1.8
mmol/l
7.1
6.8
0.20
24
142
(40768795) Lymph node Pathology biopsy report
35
264
1.33
0.86
1.1
1.2
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
31
230
1.35
0.84
1.7
2.3
—
—
—
0
0
(3043870) Heparin induced platelet Ab [Units/volume] in Serum
6
31
1.94
0.84
1.2
1.2
—
—
—
0
0
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
8
45
1.78
0.84
1.0
1.1
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
2994
29567
1.07
0.83
4.4
4.0
mmol/l
1.3
1.4
15.33
2776
27756
(3014702) Chromogranin A [Moles/volume] in Serum or Plasma
37
283
1.31
0.83
4.7
3.1
nmol/l
15.7
24.5
0.18
32
275
(3014891) Appearance of Pleural fluid
6
32
1.88
0.81
1.7
1.7
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
12
73
1.65
0.81
1.7
1.8
—
—
—
0
0
(3023487) Leukocytes [#/volume] in Peritoneal fluid
14
89
1.58
0.81
1.7
2.0
e6/l
904.0
834.5
—
6
67
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1216
11734
1.05
0.81
4.3
4.2
ug/l
2.5
2.8
0.32
1096
10667
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
8
47
1.70
0.80
1.8
1.7
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
23
164
1.40
0.79
1.2
1.3
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
40
312
1.29
0.79
1.2
1.1
—
—
—
0
0
(3017509) Phencyclidine [Presence] in Urine
6
33
1.82
0.79
2.3
1.8
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
3011
29755
1.07
0.79
4.5
4.1
mmol/l
4.6
4.7
9.37
2823
28036
(40761539) Cells [Type] in Urine sediment by Light microscopy
11
66
1.67
0.78
1.2
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
21
148
1.42
0.77
2.0
1.7
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
320
3459
0.92
0.77
1.7
1.7
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
16
107
1.50
0.76
1.1
1.2
—
0.1
—
0
10
(3004775) Volume in Urine collected for unspecified duration
28
209
1.34
0.75
3.4
2.3
ml
701.0
630.2
0.57
20
141
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
53
646
0.82
0.74
1.3
1.4
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
209
2300
0.90
0.74
1.4
1.4
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
17
116
1.47
0.74
1.3
2.2
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
7
38
1.84
0.73
1.0
1.2
—
—
—
0
0
(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
5
25
2.00
0.72
1.6
1.0
—
11.8
—
0
5
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
13
84
1.55
0.71
1.1
1.2
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
59
707
0.83
0.70
1.3
1.5
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
63
527
1.20
0.70
1.2
1.2
u/ml
28.6
48.1
—
6
45
(3027008) Opiates [Presence] in Urine
182
1646
1.11
0.69
3.6
2.1
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
44
355
1.24
0.69
2.5
2.5
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
54
650
0.83
0.68
1.3
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
54
649
0.83
0.67
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
54
648
0.83
0.66
1.3
1.4
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
28
1.79
0.66
1.8
2.3
ng/l
89.2
156.2
—
5
28
(3045462) Protein/Creatinine [Ratio] in Urine
7
44
1.59
0.65
2.7
7.0
g/mol
17.7
1043.6
—
7
44
(3022621) pH of Urine by Test strip
171
1550
1.11
0.64
3.3
2.4
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
11
166
0.66
0.64
8.3
6.8
—
—
—
0
0
(4094501)
93
812
1.15
0.64
1.1
1.1
—
—
—
0
0
(3034274) Bile acid [Moles/volume] in Serum --fasting
37
296
1.25
0.63
2.1
2.5
umol/l
11.7
9.0
0.23
27
212
(3047352) Trisomy 18 risk [Likelihood] in Fetus
44
535
0.82
0.63
1.3
1.4
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
15
104
1.44
0.62
1.0
1.7
—
—
—
0
0
(3035933) Granulocytes/100 leukocytes in Blood
14
96
1.46
0.61
1.3
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
181
1651
1.10
0.61
3.7
2.2
—
—
—
0
0
(3034426) Prothrombin time (PT)
16
113
1.42
0.61
1.1
1.2
—
—
—
0
0
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
13
88
1.48
0.60
1.5
2.1
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
22
0.00
0.59
0.0
1.1
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
172
1569
1.10
0.59
2.8
3.4
pmol/l
4.5
4.6
0.36
149
1405
(3011288) Drugs identified in Urine by Screen method
119
1065
1.12
0.58
2.9
3.7
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
26
202
1.29
0.57
1.3
1.2
—
45.6
—
0
12
(4027681)
27
211
1.28
0.57
1.3
1.3
—
—
—
0
0
(36304617) Golimumab [Mass/volume] in Serum or Plasma by Immunoassay
6
36
1.67
0.56
2.7
1.8
mg/l
4.3
1.4
—
6
30
(3000764) Benzodiazepines [Presence] in Urine
179
1641
1.10
0.56
3.7
2.2
—
—
—
0
0
(40757494) Bilirubin.total [Moles/volume] in Blood
20
150
1.34
0.55
2.7
2.2
—
28.7
—
0
13
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
37
1.62
0.55
1.3
1.8
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
6
37
1.62
0.55
1.7
1.9
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
46
548
0.84
0.55
1.3
1.5
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
49
413
1.19
0.54
1.4
1.3
mmol/l
7.7
7.2
0.46
34
305
(3001556) Androgen free Index in Serum or Plasma
6
39
1.54
0.53
1.3
1.2
—
—
—
0
0
(3048879) Bone marrow aspiration report
9
62
1.45
0.53
1.6
2.3
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
49
577
0.85
0.52
2.1
1.7
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
25
196
1.28
0.52
1.8
3.0
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
20
152
1.32
0.52
1.1
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
45
533
0.84
0.52
1.3
1.4
—
—
—
0
0
(4133840)
6
100
0.60
0.51
1.3
1.1
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
10
67
1.49
0.49
1.2
1.1
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
10
67
1.49
0.49
4.0
6.3
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
21
163
1.29
0.48
1.1
1.2
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
11
76
1.45
0.48
4.5
6.3
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
7
47
1.49
0.47
1.9
2.4
mmol/l
1.2
1.2
—
7
47
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
7
47
1.49
0.47
1.0
1.1
—
—
—
0
0
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
33
398
0.83
0.47
1.0
1.1
u/ml
0.0
0.4
—
6
91
(3023430) Cat dander IgE Ab [Units/volume] in Serum
37
441
0.84
0.47
1.0
1.1
u/ml
3.6
5.0
0.32
15
179
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
10
68
1.47
0.47
1.0
1.1
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
68
1.47
0.47
1.1
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
36
300
1.20
0.46
1.4
1.2
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
17
129
1.32
0.45
1.0
1.1
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
69
1.45
0.44
1.0
2.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
10
69
1.45
0.44
1.0
2.3
—
—
—
0
0
(3041806) Other cells [#/volume] in Blood by Manual count
9
127
0.71
0.43
2.6
1.5
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
12
87
1.38
0.42
1.1
1.2
—
—
—
0
0
(4015189)
8
57
1.40
0.42
1.4
2.2
—
—
—
0
0
(40759057) Lysozyme [Mass/volume] in Cerebral spinal fluid
0
15
0.00
0.41
0.0
1.2
—
0.0
—
0
10
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
27
222
1.22
0.41
1.7
1.6
—
—
—
0
0
(3018738) Hemoglobin F/Hemoglobin.total in Blood
0
17
0.00
0.40
0.0
3.8
—
5.7
—
0
7
(3036312) Salmon IgE Ab [Units/volume] in Serum
0
17
0.00
0.40
0.0
1.0
—
0.8
—
0
11
(3027035) Albumin [Mass/time] in 24 hour Urine
5
34
1.47
0.40
1.6
1.2
—
866.8
—
0
6
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
5
34
1.47
0.40
1.4
1.1
—
—
—
0
0
(3016750) Collection duration of Urine
20
159
1.26
0.40
3.6
2.1
min
491.7
487.2
0.10
15
114
(3027944) Amphetamines [Presence] in Urine
173
1615
1.07
0.40
3.9
2.2
—
—
—
0
0
(40768793) Breast Pathology biopsy report
51
446
1.15
0.39
1.2
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
60
531
1.13
0.39
1.8
2.0
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
5
35
1.43
0.39
4.2
3.5
—
—
—
0
0
(3041678) Intrinsic coagulation system thromboelastography panel - Blood
0
19
0.00
0.39
0.0
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
16
124
1.29
0.38
1.2
1.6
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
49
429
1.14
0.38
1.1
1.2
—
—
—
0
0
(3014133) Dog dander IgE Ab [Units/volume] in Serum
41
472
0.87
0.37
1.0
1.1
u/ml
1.7
3.9
1.56
17
193
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
14
107
1.31
0.37
2.0
2.1
—
—
—
0
0
(44806071)
5
37
1.35
0.37
1.0
1.0
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
49
556
0.88
0.36
1.0
1.1
u/ml
0.6
2.3
—
9
137
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
19
153
1.24
0.35
1.1
1.6
—
—
—
0
0
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
11
82
1.34
0.34
1.5
1.4
ug/l
7.7
8.4
0.58
11
82
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
6
45
1.33
0.33
1.7
1.2
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
27
228
1.19
0.33
1.2
1.3
—
1.5
—
0
14
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
6
86
0.70
0.33
1.0
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
24
201
1.20
0.32
1.5
1.3
u/ml
0.3
0.5
—
8
90
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
15
187
0.80
0.32
1.1
1.2
ratio
1.1
1.1
—
6
72
(3018980) carBAMazepine [Moles/volume] in Serum or Plasma
13
101
1.29
0.31
1.5
2.8
umol/l
31.2
29.5
—
8
71
(40757373) Influenza virus identified in Isolate
7
52
1.35
0.31
1.3
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
59
653
0.90
0.31
1.2
1.2
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
22
184
1.20
0.30
2.0
1.8
u/field
1.8
1.8
0.01
13
83
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
7
54
1.30
0.30
1.1
1.5
—
—
—
0
0
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
7
54
1.30
0.30
4.3
7.1
—
—
—
0
0
(3034988) Calcium [Moles/volume] in Capillary blood
7
54
1.30
0.30
1.4
2.3
mmol/l
1.2
1.2
—
7
54
(3020191) Ethanol [Moles/volume] in Serum or Plasma
34
296
1.15
0.30
1.6
1.4
promille
1.6
1.4
0.29
29
228
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
31
268
1.16
0.30
1.2
1.2
mg/l
48.3
45.4
0.08
23
213
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
10
75
1.33
0.30
1.1
1.1
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
21
175
1.20
0.30
1.1
1.3
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
11
84
1.31
0.30
1.0
1.0
—
—
—
0
0
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
30
259
1.16
0.29
1.1
1.1
mg/l
297.0
296.8
0.00
24
221
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
367
3541
1.04
0.29
1.5
1.5
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
50
449
1.12
0.29
1.2
1.2
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
35
307
1.14
0.28
1.3
1.4
ug/l
2.0
4.1
1.86
27
280
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
11
85
1.29
0.28
1.1
1.2
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
83
895
0.93
0.27
1.6
1.6
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
21
178
1.18
0.26
1.0
1.0
u/ml
0.7
2.9
—
7
53
(3037556) Urate [Mass/volume] in Serum or Plasma
9
76
1.18
0.24
1.1
1.3
—
—
—
0
0
(3018658) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum
17
142
1.20
0.24
1.2
1.1
u/ml
13.2
7.0
—
5
15
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
68
628
1.08
0.24
1.6
1.9
iu/l
3.7
4.9
0.88
22
232
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
10
78
1.28
0.24
1.1
1.2
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
48
436
1.10
0.24
1.1
1.1
—
—
—
0
0
(3009677) Dengue virus Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.2
—
—
—
0
0
(3043649) Fibrin monomer [Presence] in Platelet poor plasma by Hemagglutination
0
11
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
10
0.00
0.21
0.0
1.9
—
—
—
0
0
(3042951) Complement C1q Ab [Units/volume] in Serum
0
12
0.00
0.21
0.0
1.1
—
29.8
—
0
5
(3032868) Hemoglobin electrophoresis panel in Blood
5
43
1.16
0.21
1.4
1.5
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
20
173
1.16
0.21
12.8
7.3
u/ml
37.6
13045.6
—
9
49
(3008799) Glucose [Moles/volume] in Serum or Plasma --30 minutes post dose glucose
0
14
0.00
0.20
0.0
1.1
—
8.4
—
0
14
(3005011) Chlamydia sp Ab [Titer] in Serum
6
50
1.20
0.19
1.3
1.4
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
6
50
1.20
0.19
1.8
2.2
mmol/l
2.5
2.7
—
6
45
(3001019) Free T4 and TSH panel - Serum or Plasma
165
1717
0.96
0.19
1.6
1.6
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
11
90
1.22
0.19
1.3
1.5
—
—
—
0
0
(43055246) Days in therapeutic INR range/Days INR result determined [Ratio]
6
52
1.15
0.19
22.3
5.6
%
60.5
72.1
—
6
43
(3002619) Bacteria identified in Specimen by Culture
7
58
1.21
0.18
1.3
1.1
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
7
60
1.17
0.17
2.4
3.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
69
0.72
0.17
1.0
1.2
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
17
194
0.88
0.16
1.1
1.1
u/l
1.0
1.1
—
6
99
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
8
69
1.16
0.16
1.1
1.4
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
929
9406
0.98
0.16
3.8
3.7
%
21.4
21.8
0.30
388
4129
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
16
183
0.87
0.16
1.7
1.6
mmol/l
8.7
7.7
—
10
118
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
694
6839
1.02
0.16
2.7
2.7
ug/l
0.7
0.7
1.53
426
4128
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
23
255
0.90
0.15
4.4
4.9
u/ml
160.4
95.3
—
7
68
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
9
81
1.11
0.15
1.0
1.1
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
98
938
1.05
0.14
1.4
1.3
miu/ml
257.3
212.8
0.43
36
437
(3051387) C reactive protein [Mass/volume] in Capillary blood
55
584
0.94
0.14
3.3
2.9
mg/l
23.2
26.2
0.29
34
364
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
29
316
0.92
0.14
1.6
1.6
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
10
118
0.85
0.14
1.0
1.2
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
117
1215
0.96
0.14
1.7
1.7
mg/l
4.5
3.7
0.21
95
841
(3006462) Nitrate [Presence] in Urine
12
103
1.17
0.13
2.7
2.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
186
1809
1.03
0.13
1.2
1.2
iu/ml
127.0
145.3
0.20
57
663
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
35
376
0.93
0.13
1.3
1.3
pmol/l
42.0
153.4
0.77
16
115
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
327
3210
1.02
0.12
1.7
1.6
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
13
114
1.14
0.11
1.0
1.1
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
21
192
1.09
0.10
1.2
1.1
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
27
251
1.08
0.10
1.2
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
46
1.09
0.09
1.2
3.3
—
—
—
0
0
(3017704) Immunofixation for Urine
16
145
1.10
0.09
1.8
1.7
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
54
1.11
0.09
1.7
2.2
—
—
—
0
0
(3029396) Erythrocyte agglutination [Presence] in Blood
6
58
1.03
0.08
3.7
2.9
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
6
58
1.03
0.08
1.2
1.2
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
10
113
0.88
0.08
1.2
1.2
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
5
62
0.81
0.08
1.2
1.4
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
20
185
1.08
0.08
1.0
1.0
u/ml
0.5
1.2
—
6
47
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
5
65
0.77
0.08
1.0
1.0
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
5
65
0.77
0.08
1.0
1.0
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
5
65
0.77
0.08
1.0
1.0
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
5
65
0.77
0.08
1.0
1.0
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
9
85
1.06
0.07
1.3
1.2
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
22
206
1.07
0.07
1.6
1.8
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
92
0.87
0.06
1.1
1.1
—
—
—
0
0
(4198724)
19
177
1.07
0.06
2.2
3.0
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
81
789
1.03
0.06
1.5
1.5
—
—
—
0
0
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
68
661
1.03
0.06
1.0
1.1
u/ml
0.8
1.4
0.65
26
272
(3003888) Timothy IgE Ab [Units/volume] in Serum
60
583
1.03
0.05
1.1
1.1
u/ml
9.7
5.2
0.73
28
317
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
16
150
1.07
0.04
1.5
1.5
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
81
795
1.02
0.04
1.4
1.5
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
12
111
1.08
0.04
1.0
1.0
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
18
172
1.05
0.02
1.1
1.2
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
22
228
0.96
0.02
1.0
1.1
—
—
—
0
0
(4211845)
12
114
1.05
0.00
2.7
2.8
—
—
—
0
0
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
12
122
0.98
0.00
1.2
1.6
%
219.1
141.6
1.09
12
116
(3025577) Chromium [Mass/volume] in Blood
15
155
0.97
0.00
1.8
2.1
ug/l
1.0
2.4
—
9
134
(3014043) Spermatozoa Nonprogressive/100 spermatozoa in Semen
16
165
0.97
0.00
6.0
5.9
—
—
—
0
0
(40761995) Spermatozoa Progressive [#/volume] in Semen
16
165
0.97
0.00
3.0
3.0
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
17
175
0.97
0.00
4.4
2.4
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
56
562
1.00
0.00
1.0
1.1
u/ml
1.3
1.2
0.05
22
249
(4024509)
21
209
1.00
0.00
1.3
1.4
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
6
0.00
0.00
0.0
1.0
—
2737.8
—
0
6
(3022689) Creatine [Moles/volume] in Urine
8
80
1.00
0.00
1.3
1.4
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051596) Benzodiazepines [Presence] in Serum or Plasma by Screen method
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016135) IgD [Mass/volume] in Serum
0
9
0.00
0.00
0.0
1.0
—
45.1
—
0
9
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3027505) Alpha-1-Fetoprotein [Units/volume] in Amniotic fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
9
95
0.95
0.00
6.9
10.4
—
—
—
0
0
(3018291) Platelet Ab [Presence] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
9
97
0.93
0.00
1.0
1.2
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
5
50
1.00
0.00
1.0
1.1
—
—
—
0
0
(3004282) Tumor necrosis factor.alpha [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
3.0
—
8.3
—
0
7
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.2
—
2.4
—
0
5
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3018081) Beta-2-Microglobulin [Mass/volume] in Urine
0
9
0.00
0.00
0.0
1.4
—
11.4
—
0
9
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
268.0
—
0
7
(3009385) Beta-2-Microglobulin [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.2
—
1.3
—
0
5
(44806420)
5
59
0.85
0.00
1.8
2.2
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3010657) Triiodothyronine (T3) Free [Mass/volume] in Serum or Plasma by Dialysis
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
5
54
0.93
0.00
1.4
1.1
u/ml
6.5
5.5
—
5
41
(3002719) Hemoglobin [Mass/volume] in Urine
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3003157) Bacteria [#/volume] in Mother's milk
0
5
0.00
0.00
0.0
9.0
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
9
98
0.92
0.00
1.0
1.2
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
2.0
—
0
7
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017400) Magnesium [Moles/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
2.0
—
0
5
(3012920) Ethanol [Mass/volume] in Serum or Plasma
0
8
0.00
0.00
0.0
1.8
—
—
—
0
0
(3046904) Somatotropin [Units/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
1.3
—
0
7
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
6
60
1.00
0.00
1.3
1.1
—
—
—
0
0
(1175825) Sexually transmitted pathogens panel - Specimen by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3008860) Bordetella pertussis IgM Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0

Mortality – FinRegistry

Association

Association between endpoint K11_ABSCANAL and mortality.

Females

Parameter HR [95% CI] p-value
K11_ABSCANAL 2.182 [1.89, 2.52] < 0.001
Birth year 1.002 [0.99, 1.01] 0.616

During the follow-up period (1.1.1998 — 31.12.2019), 696 out of 6027 females with K11_ABSCANAL died.

Males

Parameter HR [95% CI] p-value
K11_ABSCANAL 2.027 [1.82, 2.26] < 0.001
Birth year 0.991 [0.98, 1.0] 0.038

During the follow-up period (1.1.1998 — 31.12.2019), 1799 out of 14401 males with K11_ABSCANAL died.

Mortality risk

Mortality risk for people of age

years, who have K11_ABSCANAL.

N-year risk Females Males
1 0.3% 0.403%
5 1.548% 2.447%
10 3.758% 5.958%
15 7.344% 11.286%
20 12.987% 19.161%

Relationships between endpoints

Index endpoint: K11_ABSCANAL – Abscess of anal and rectal regions

GWS hits: 3

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data